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ABSTRACT
Complete sequencing and annotation of the M. leprae genome has provided new
information related to proteins constituting its hypothetical proteome. Since M. leprae
can not be grown in vitro, novel approaches are needed to determine which proteins are
expressed during infection and whether these proteins are related to pathogenesis.
Secreted proteins represent a distinct group of protein with respect to their structure and
function, contribution to virulence and are of particular importance for vaccine
development because they are often immunogenic and have the potential to be recognized
early in infection. The objectives of this study were: 1) to identify putatively secreted
proteins of M. leprae based on protein sequences homologies with known MT secreted
proteins; 2) to apply bioinformatic tools designed to assess proteins for secretion, to
proteins selected in objective 1 with the goal of improving the likelihood that selected
proteins are secreted by M. leprae, 3) to validate secretion of selected ML proteins
through genetic cloning of predicted secreted ML protein genes using surrogate host
bacteria, E. coli and M. smegmatis.
Bioinformatics identified 24 proteins with high probability for secretion in M.
leprae. Fifteen of 24 ML genes showed more than 50% amino acid homology with their
M. tuberculosis counterparts and were studied for gene expression and secretion. mRNA
analysis identified transcripts for all Sec-dependent pathway proteins of 15 genes
predicted to be secreted in M. leprae. PhoA fusion studies in E. coli showed that 5 of 6
(83%) ML proteins (ML0091, ML0097, ML0620, ML1811 and ML1812) were secreted
in E. coli and 2 of 7 (29%) proteins (ML0715 and ML2569) were secreted in M.
smegmatis. Only lipoproteins were secreted in M. smegmatis suggesting the importance

vii

of mycobacterial-related characteristics for secretion of ML lipoproteins. These results
suggest that bioinformatic tools are reliable predictors for identifying secreted proteins in
M. leprae and support the hypothesis that Sec-dependent secretion exists in M. leprae.

viii

INTRODUCTION
Secreted proteins represent a distinct group of proteins with respect to their
structure and function and contribution to virulence. They are of particular importance for
vaccine development because they are often immunogenic and have the potential to be
recognized early in infection. Little is known regarding mycobacterial protein secretion.
Elucidation of protein secretion in M. leprae could provide new insights into virulence
factors of M. leprae and provide a source of proteins with potential for vaccine
development.
A requisite step in protein secretion is protein translocation across the cytoplasmic
membrane. This step is common to proteins that are released to the extracellular space or
remain associated with the cell wall. The Sec-dependent pathway translocates precursor
proteins containing N-terminal signal sequences across the cytoplasmic membrane
(Oliver and Beckwith, 1981). Four different experimental approaches have been used to
study M. tuberculosis secreted proteins. One is the analysis of culture filtrates that
contains as many as 200 proteins (Sonnenberg and Belisle, 1997). This procedure has
been used to study cultivable mycobacteria, such as M. tuberculosis and M. bovis,
however, it cannot be applied to M. leprae since the bacteria must be harvested from
infected host tissues where secreted proteins are lost during isolation of the bacilli.
A second approach, comparative genomics, can be used to study secretion in M.
leprae by identifying gene sequences for M. tuberculosis or other mycobacteria secreted
proteins and using these proteins to identify homologs in the M. leprae genome. A third
approach for studying secretion utilizes bioinformatics tools which consists of computer
algorithms capable of predicting various properties of proteins. Location (e.g.,
cytoplasmic, cell membrane, secreted) of proteins have been predicted accurately using
1

this approach (Wiker et al, 2000). While comparative genomics and bioinformatics are
powerful analytical tools, results must be authenticated in biological systems. Genetic
approaches have been used for authentication of secretion by making gene fusions with
reporter genes encoding enzymes that become active upon translocation across the cell
membrane (e.g. alkaline phosphatase, Hoffman and Wright, 1985).
The following chapters describe studies designed to characterize secreted proteins
in M. leprae using comparative genomics, bioinformatics (Chapter 2) and authentication
of secretion by phoA-ML gene fusions (Chapter 3).
Chapter 2 reports the use of a computer strategy to predict M.leprae secreted
proteins taking advantage of the recently released M. leprae genome (Cole et al, 2001).
Two different programs were used to identify proteins having secretory signal peptides
but lacking additional membrane attachment domains: SignalP was used to predict the
presence and location of signal peptide cleavage sites in amino acid sequences and
Transmembrane Hidden Markov Model (TMHMM) was used to predict the location and
orientation of transmembrane helices in protein sequences.
Chapter 3 describes the results from gene transcription studies of 15 ML proteins
predicted to be secreted using SignalP and TMHMM. The mRNA was purified from ML
grown in nude mice and gene expression was monitored by RT-PCR. Each gene was
cloned into 2 separate reporter plasmids in an attempt to demonstrate protein secretion in
either E. coli or M. smegmatis.
The hypothesis of this study is “M. leprae produces secreted proteins and
SignalP/TMHMM are reliable bioinformatics tools to identify secreted proteins with
special Sec-dependent characteristics.

2

The results of this work should help improve the understanding of Sec-dependent
secretion in M. leprae and provides a listing of ML proteins with potential for
development as vaccines or as diagnostic reagents capable of adding to current strategies
for controlling leprosy.
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CHAPTER 1
LITERATURE REVIEW
1.1. Leprosy
Gerhard Hansen was the first to recognize that leprosy was caused by a bacterium,
M. leprae, and in so doing identified the first human bacterial pathogen (Hansen, 1874).
In 1960, Shepard described the limited multiplication of M. leprae which occurs when M.
leprae are injected into the footpads of immunocompetent mice. This model made it
possible for the first time to screen drugs for anti-leprosy activity, diagnose drug-resistant
leprosy and study certain aspects of immunity to M. leprae, including evaluation of
leprosy vaccines. Although M. leprae has not been cultured in routine laboratory media,
in the late 1960s armadillos, nude mice, and immunosuppressed rats were shown to yield
high numbers of M. leprae following infection. This has greatly increased the availability
of M. leprae and permitted investigations into the genetics of M. leprae and the
pathogenesis of leprosy.
1.1.1. Epidemiology
One-hundred three countries reported new leprosy cases for 2003 totalling
524,000 globally. The global leprosy prevalence for 2002 was 612,000 (WHO). The
global prevalence of leprosy has been significantly reduced from the estimated 10-15
million cases reported a decade ago as a result of the World Health Organization program
for global elimination of leprosy as a public health problem, based on the worldwide
implementation of multidrug therapy (MDT). The implementation of MDT had a
significant effect on reducing the prevalence of leprosy, but the incidence of the disease
has remained steady for the last 10-15 years at a rate of around 500,000-600,000 new
cases per year. These data suggest that to truly eradicate leprosy other forms of
4

intervention such as tools for early diagnosis and prevention by vaccination may be
necessary.
Physical deformities in leprosy, which are permanent and often progressive, result
in both reduced opportunities for patients and, in areas where leprosy is highly endemic,
economic loss to the community. The consequences of leprosy related deformities and
disabilities are much more pronounced than other disabilities due to the added effects of
social disability resulting from the stigma attached to the disease.
Unlike many other communicable diseases, there is considerable difficulty in
identifying the three reference points that are involved in the transmission of leprosy. The
identification of the point of onset of infection is the most important and difficult of the
problems in the study of transmission. The human being is the only known reservoir of
infection in leprosy, with the exception that naturally occurring disease with organisms
indistinguishable from M. leprae has also been detected among wild armadillos in parts
of the southern United States and Brazil. Up to 5% of armadillos in Louisiana have been
found to have clinical disease, with about 20% having serological evidence of M. leprae
infection (Truman et al, 1986). In addition, primates (Meyers et al, 1991) and
chimpanzees (Leininger et al, 1980) naturally infected with M. leprae have been
identified.
1.1.2. Clinical Disease
Clinical disease is categorized into two polar forms, tuberculoid (TT) and
lepromatous (LL) leprosy and variations between the two polar forms are referred to as
borderline leprosy.
TT exhibits one or a few circumscribed skin lesions containing rare demonstrable bacilli.
Aspects of cellular immunity appear to be active in the pathogenesis of TT leprosy as the
5

characteristic histological picture is one of well formed granulomas. LL is the
disseminated form of the disease and the patient lacks demonstrable cell-mediated
immunity (CMI) against M. leprae, resulting in disseminated growth of the bacilli. Nerve
involvement in early LL is less severe than TT disease due in part to lack of CMI, but as
the disease progresses, deformities may occur resulting from nerve invasion by massive
numbers of bacilli. The majority of leprosy cases fall into the borderline classification.
The major divisions of borderline disease are borderline tuberculoid (BT) and borderline
lepromatous (BL). The gross appearance of leprosy along the disease spectrum from BT
to BL generally reflects more numerous and disseminated lesions. The bacteria within
lesions become more abundant and histopathological evidence of CMI diminishes as the
clinical spectrum moves from BT to BL. Because borderline patients have significant
levels of bacilli in their tissues and an active, although limited, immunological capacity to
recognize M. leprae, they suffer from the greatest degree of nerve damage and related
deformities (Gillis and Krahenbuhl, 1998).
The natural course of leprosy often involves complications referred to as leprosy
reactions. Reactions occur due to invasion of tissue by M. leprae and resultant
immunological activity. The term reaction is used to describe the appearance of
symptoms and signs of acute inflammation in lesions of patients with leprosy.
There are two types of reactions:
- Type 1, associated with cell-mediated hypersensitivity, occurs in patients with
tuberculoid and borderline leprosy. Untreated, type 1 reactions may last for months or
years, and can relapse unexpectadely. Neuritis is the most important consequence of a
type 1 reaction and it may occur together with skin changes or independently, possibly
reflecting hypersensitivity to different antigens of M. leprae.
6

- Type 2 reactions are thought to be associated with immune complexes and are
also known as erythema nodosum leprosum (ENL). Type 2 reactions occur in patients
with multibacillary disease and cause acute inflammation in any organ or tissue where M.
leprae are found. ENL is seen primarily in BL and LL patients who produce large
amounts of antibody to M. leprae (Hastings, 1994).
1.1.3. Immunology
In TT leprosy a strong cellular immune response to M. leprae is associated with
limited disease and few, if any, demonstrable bacilli within granulomas located in the
dermis and peripheral nerves. By contrast, in LL leprosy the absence of a cellular
immune response leads to the uncontrolled proliferation of leprosy bacilli, extensive
clinical lesions and a strong antibody response to mycobacterial antigens. In the
borderline forms of leprosy progressive reduction in the cellular immune response and
delayed- type hypersensitivity to M. leprae from BT to BL disease is accompanied by
more frequent skin and nerve lesions, a greater bacillary load and increasing antibody
levels (Waters, 1992).
Activation of the cellular immune response to M. leprae is dependent on the
initial interaction of T cells and antigen presenting cells (APC). Immunohistochemical
studies have established the predominance of CD4+ over CD8+ T cells in lesions of TT
leprosy patients at a ratio 2:1, while in BL/LL lesions there are far fewer lymphocytes
and similar proportions (1:1) of CD4+ and CD8+ T cells (Mehra and Modlin, 1989).
In tuberculoid leprosy, the granuloma is organized in distinct immunological
microenviroments. The core of the granuloma is composed of well-differentiated
macrophages and epithelioid cells diffusely infiltrated with CD4+ T lymphocytes. The
predominant localization of CD8+T cells at the periphery of the granulomas suggests a
7

role in localizing the granulomatous reaction (Hastings, 1994). By contrast, the
granuloma of lepromatous leprosy does not show this compartmentalization of CD4 and
CD8 lymphocytes. CD4 and CD8 cells are distributed evenly throughout the granuloma
and at an equal ratio. This arrangement of CD4 and CD8 T cells may reflect a relatively
inefficient host response, allowing virtually uninhibited bacillary proliferation. The lack
of a surrounding mantle of CD8 T cells may also facilitate the dissemination of the
granulomatous response.
One study of cytokine mRNA production in leprosy lesions using reverse
transcriptase polymerase chain reaction (RT PCR) demonstrated a predominance of IL-2
and IFN-γ transcripts in TT lesions, while IL-4, IL-5 and IL-10 were more apparent in LL
lesions (Yamamura et al, 1991). These results are in agreement with the Th1/Th2
paradigm of Mosmann and Coffman, 1989, and help explain the immunological spectrum
underlying clinical leprosy. In addition, Th1 cells play a central part in the activation of
cellular immune mechanisms whereas Th2 cells are of crucial importance for humoral
immunity.
Cells of the monocyte/macrophage lineage play various roles in the parasite/host
relationship in leprosy, serving as cellular habitat for M. leprae, activators of T cells as
antigen-presenting cells (APC), and effector cells in destruction of the bacillus. Other
cells such as dendritic cells, Langerhans cells, B cells and endothelial cells can act as
APC, but macrophages are uniquely efficient because they are capable not only of
endocytosis of soluble antigens, but they can also phagocytose particulate antigens and
present them for stimulation of CMI in a major histocompatibility complex (MHC) class
II restricted context. By secretion of T cell amplifying cytokines such as IL-1 and tumor
necrosis factor alpha (TNFα), macrophages can up-regulate CMI.
8

The immunological understanding of clinical leprosy continues to be dominated
by the unusual specific anergy to M. leprae in LL. This minority of leprosy patients are
unable to mount and efficient CMI to M. leprae. It is not known whether this specific
immunodeficiency is predetermined, e.g., by genetic factors, by the kind and extent of
exposure to other mycobacteria prior to infection with M. leprae, or is induced by M.
leprae itself (Hastings, 1994). Based on the current understanding of the immunological
events observed in leprosy a vaccine capable of inducing a Th1-type response to M.
leprae in tissues may be capable of preventing the initial infection in TT and borderline
leprosy, but may not in LL disease.
1.2. Potential Significance of ML Secreted Proteins
Proteins released by mycobacteria to the extracellular environment have been the
focus of research directed at identifying antigens that induce protective immunity and that
may be involved in pathogenesis. Living mycobacteria are significantly more effective as
inducers of protective immunity than dead bacilli (Bloch and Segal, 1955) and several
studies have shown that the majority of bacterial virulence factors are extracellular
proteins (Finlay and Falkow, 1997, and Miller and Cossart, 1999).. These observations
underscore the importance of understanding secretion in M. leprae with the intent of
identifying secreted proteins with potential for vaccine development and that may play a
role in the pathogenesis of leprosy.
Secreted proteins of M. tuberculosis are believed to be responsible in part for the
efficacy of the live vaccine, M. bovis BCG, used against tuberculosis and leprosy.
Shepard tried different mycobacterial preparations to measure protection in mice when
challenged with M. leprae. The protection provided by BCG was markedly reduced when
the vaccine was heated at 60ºC for 30 minutes killing the bacteria (Shepard et al, 1978).
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A study in Malawi showed that a second BCG vaccination reduced the risk of leprosy by
about 50% among individuals who had received BCG vaccination in the past. There was
no evidence that addition of killed M. leprae enhanced the protection against leprosy
afforded by BCG alone (Fine, 1996) suggesting that addition of static structural antigenic
components of M. leprae did not improve the vaccine potency.
Recognition of mycobacterial secreted proteins by the immune system may lead
to early detection of infected macrophages and control of the disease. Subunit vaccines
based on mixtures of culture filtrate proteins from M. tuberculosis have resulted in
protective immunity in several studies using animal models of tuberculosis (Andersen P,
1994; Hubbard et al, 1992; Pal and Horwitz, 1992; Roberts et al, 1995). Only a few of
these proteins, for example, Ag85 complex and ESAT-6, have been isolated and
characterized at present. Since M. leprae encodes homologs of these and other M.
tuberculosis secreted proteins, the M. leprae secreted proteins represent an unexplored
resource with great potential for developing new vaccines with therapeutic and
prophylactic potential.
1.3. Protein Secretion Mechanisms in Bacteria
While exported proteins are those proteins primarily associated with the cell wall
and possibly released into the culture medium over time, secreted proteins are soluble
proteins that are released into the culture supernatant and not associated with the bacteria
(Wiker et al, 1999). Prokaryotes have a number of pathways dedicated to the process of
protein secretion. In general, these organisms translocate the majority of their secreted
proteins via the Sec pathway. There are at least 6 different pathways for protein secretion
known in Gram-negative bacteria as reviewed by Thanassi and Hultgren, 2000. Four of
these pathways release proteins with cleavable amino-terminal signal sequences to the
10

extracellular space in a two-step process that requires the Sec pathway for translocation
across the inner membrane. The four pathways are autotransporters, chaperone/usher,
type II and type IV secretion. The other pathways are Sec-independent and capable of
exporting substrates in one step to the extracellular space. These pathways are type I and
type III secretion. An alternate secretion mechanism, the twin-arginine translocation (Tat)
pathway, was originally identified in chloroplasts and has recently been found in bacteria
and Archae (Santini et al, 1998). Tat signal peptides are similar to Sec signal peptides,
but they contain a highly conserved twin-arginine motif. Mycobacterium species possess
the genes required to translocate proteins by both the Sec and twin-arginine pathways.
Various approaches have been used to study secretion and secreted proteins from
bacteria. Analysis of in vitro culture filtrates showed that M. tuberculosis produces as
many as 200 putatively secreted proteins (Sonnenberg and Belisle, 1997). Whereas this
approach has been used successfully for cultivable bacteria, it is inappropriate for similar
studies with the leprosy bacillus since M. leprae must be harvested from infected tissues
resulting in the loss of secreted proteins from the purified bacilli.
A second approach for studying secreted proteins utilizes comparative genomics
and is readily applicable to studying M. leprae secreted proteins. For example, genes
known to encode secreted proteins in M. tuberculosis can be used to search the genome
of M. leprae for sequences with strong DNA sequence similarities. If these regions of
similarity appear to encode genes with potential for secretion, then the M. leprae genes
can be cloned and studied further to verify transcription, translation and secretion.
Bioinformatics can also be used to support comparative genomic studies by
providing tools for predicting properties of proteins, including cellular location.
Computer algorithms have been developed that predict whether a protein is located
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within the cytoplasm, the cell membrane or exported from the cell. Proteins predicted for
secretion by either comparative genomics or bioinformatics approaches require validation
in biological systems. Genetic tools can help bridge the gap between in silico predictors
and in situ authentication. A particularly useful genetic tool for this purpose utilizes gene
fusion technology in which an unknown gene, suspected of being secreted, is fused to a
reporter gene (e.g., alkaline phosphatase) which acts to signal the secretion event upon
translocation. For mycobacterial genes, including M. leprae, validation of secretion can
be accomplished by cloning M. leprae-reporter fusion genes into E. coli or M. smegmatis.
1.3.1. Signal Sequence Dependent Mechanisms for Translocation
- Sec Pathway
The Sec pathway translocates precursor proteins containing N-terminal signal
sequences across the cytoplasmic membrane. The work of Oliver and Beckwith, 1981,
established that the translocation of precursor proteins across the cytoplasmic membrane
of E. coli requires the products of at least six genes. These genes, secA, secB, secD, secE,
secF, and secY, encode interacting core-components of a complex translocation apparatus
that consists of soluble and membrane integrated proteins. SecA is an ATPase that
performs a central role in bacterial protein secretion, as it is the molecular motor that
drives translocation. During the last few years, genes encoding SecA homologs from
many different Gram-positive organisms, have been cloned (Klein et al, 1995; Blanco et
al, 1996; Braunstein et al, 2001; Limia et al, 2001). The SecA protein binds the SecYEG
complex to form the translocase, which mediates the ATP translocation of precursor
proteins across the membrane. Proteins are secreted through an aqueous channel formed
by the SecY, SecE and SecG polypeptides. SecY is the largest subunit of the membrane
domain of the protein translocase. SecE is a small integral membrane protein that is
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essential for translocation and viability. SecE of Gram-positive bacteria are considerably
smaller than the E. coli SecE. Gram-positive SecE sequence is homologous to the
carboxy-terminal part of the E.coli SecE, which corresponds to the highly conserved
cytosolic loop region and the third transmembrane segment. Another protein, band 1 or
SecG, copurifies and coimmunoprecipitates with SecY and SecE forming a threecomponent complex as described by Brundage, et al, 1990. Sequence analysis showed
that Gram-positive SecG have weak but significant sequence similarity with the E. coli
SecG. SecG proteins from Gram-positive bacteria tend to be shorter than their Gramnegative counterparts. Unlike SecY and SecE, SecG is not essential for viability and
protein translocation in E. coli. SecD and SecF are needed for the late stages of
translocation. SecB is a chaperone protein that forms a complex with precursor proteins
but does not catalyze folding or unfolding. SecB binds to the carboxy-terminus of Sec-A
and is essential only in rapidly growing cells. This region of SecA is highly conserved
among many Gram-negative and Gram-positive bacteria; however, no homologs with
sequence similarity to SecB are present in any of the Gram-positive organisms of which
the genome sequence has been completed. (van Wely et al, 2001).
- Twin Arginine Translocation Pathway
The twin-arginine (Tat) pathway translocates redox proteins across the
cytoplasmic membrane in E. coli (Sargent, et al., 1998) and has recently been shown to
secrete virulence factors from Psuedomonas aeruginosa (Dilks, et al., 2003). Even
though secreted peptides exhibit a highly conserved twin-arginine motif, the Tat pathway
is not universally conserved. Signal sequences for proteins in the twin-arginine pathway
are longer than those found in proteins secreted by Sec-dependent mechanisms and
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contain two arginines. The twin arginine pathway differs from the Sec pathway in that
proteins are secreted in a folded conformation.
The Tat pathway is Sec-independent as multiple Sec factors have been shown to
play no role in the process. The E. coli Tat pathway contains 4 genes (tatA, tatB, tatC
and tatD) organized in an operon with an unassociated fifth gene, tatE. Tat B and C have
essential roles in translocation, disruption of these genes leads to a complete block in the
export of a subset of periplasmic proteins (Sargent, et al, 1998). Disruption of tatD,
however, has no detectable effect on secretion suggesting TatD is not involved in the
export process. The Tat complex has been purified from E. coli and was shown to
contain only TatA, TatB and TatC (Bolhuis, et al, 2001).
1.3.2. Amino-terminal Signal Peptides
Signal peptides consist of short amino acid sequences which, after protein
delivery to the correct subcellular compartment, are frequently removed by specialized
signal peptidases. Three distinct domains of signal peptides can be recognized: The first
domain is the amino-terminal N-domain containing positively charged residues (e.g.,
arginine or lysine). The positively charged N-domain is thought to interact with the
translocation machinery and negatively charged phospholipids in the lipid bilayer of the
cytoplasmic membrane during translocation. The second domain is the H-domain which
is composed of hydrophobic residues that appear to adopt an α-helical conformation in
the membrane. Helix-breaking glycine or proline residues are frequently present in the
middle of this hydrophobic core. Helix-breaking residues found at the end of the Hdomain are thought to facilitate cleavage by a specific signal peptidase. The C-domain,
following the H-domain, contains the cleavage site for signal peptidase. The (-3, -1) rule
states that the residues at positions -3 and -1 (relative to the cleavage site) must be small
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and neutral for cleavage to occur correctly; this area is often referred to as an Ala-X-Ala
cleavage site. Alternatively, the C-domain may contain Gly or Ser in position -1 and Val,
Ser or Thr in position -3 (von Heijne, 1983).
The signal peptidase removes the signal peptide from the mature part of the
secreted protein during or shortly after translocation. The mature part of the protein is
released from the membrane and can fold into its native conformation. Finally the signal
peptide is degraded by signal peptide peptidases and removed from the membrane
(Tjalsma et al, 2000).
Four major classes of amino-terminal signal peptides can be distinguished in B.
subtilis on the basis of the signal peptidase recognition sequence. The first class is
composed of typical signal peptides which are present in preproteins that are cleaved by
one of the various type I signal peptidases. Although most proteins having such a signal
seem to be secreted into the extracellular environment, some of them are retained in the
cell wall. A subgroup of these signal peptides contain a so called twin-arginine motif
(RR-motif), which directs proteins into a distinct translocation pathway known as the Tat
pathway. The second major class of signal peptides is present in prelipoproteins, which
are cleaved by the lipoprotein-specific type II signal peptidase. Lipoproteins have a wellconserved lipobox that contains a cysteine residue that is lipid modified by the
diacylglyceryl transferase prior to cleavage by signal peptidase II. After translocation
across the cytoplasmic membrane, exported lipid-modified proteins remain anchored to
the membrane by their amino-terminal lipid-modified cysteine residue. The third major
class is formed by signal peptides of prepilin-like proteins which in B. subtilis, are
cleaved by the prepilin-specific signal peptidase ComC. The recognition sequence for the
prepilin signal peptidase is localized between the N- and H-domains, leaving the H15

domain attached to the mature pilin after cleavage. Finally, the fourth major class of
signal peptides is found on ribosomally synthesized bacteriocins and pheromones that are
exported by ABC transporters. These signal peptides lack a hydrophobic H-domain and
are removed from the mature protein by a subunit of the ABC transporter that is
responsible for the export of a particular bacteriocin or pheromone (Tjalsma et al, 2000).
1.3.3.Autotransporters
The autotransporter secretion pathway is a terminal branch of the Sec pathway
that exports proteins with diverse functions, including proteases, toxins, adhesins and
invasins. A typical autotransporter contains three domains as described by Henderson et
al, 1998: an amino-terminal signal sequence for secretion across the inner membrane by
the Sec pathway, an internal passenger or functional domain, and a carboxy-terminal βdomain. The β-domain inserts into the outer membrane to form what is predicted to be a
β-barrel pore structure, similar to the bacterial porins, through which the passenger
domain passes to the cell surface. A linker region connecting the passenger and βdomains is also essential for export and may guide the passenger region through the βdomain channel. Once secreted, the passenger domain is either retained on the bacterial
surface or released into the environment by proteolysis.
Neisseria secretes IgA protease, an enzyme that cleaves antibodies on mucosal
surfaces by the autotransporter secretion pathway. IgA protease is synthesized as a preproenzyme with an N-terminal signal peptide that initiates the precursor into the Sec
pathway. After cleavage of the signal peptide by signal peptidase, the proenzyme resides
in the bacterial periplasm. The C-terminal β-domain of IgA protease assumes a β-barrel
structure that inserts into the outer membrane and functions as an autotransporter for the
N-terminal domain. Once the N-terminal protease domain is exposed on the bacterial
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surface, it cleaves the proenzyme at the junction between the N-terminal and the Cterminal domain. The cleaved N-terminal domain of the proenzyme is released from the
bacterial surface and acts as virulence factor.
1.3.4. Chaperone/usher Pathway
The chaperone/usher pathway is a branch of the Sec pathway for secretion of a
broad range of adhesive virulence structures on the Gram-negative bacterial surface
(Thanassi et al, 1998). Secretion across the outer membrane by this pathway requires
only 2 components: a periplasmic chaperone and an outer membrane protein termed an
usher.
The assembly of P and type I pili, expressed by uropathogenic E. coli, is an
example of this pathway (Roberts et al, 1994). These pili consist of a thin, flexible tip
fibrillum connected to a rigid, helical rod. Following export across the inner membrane
via the Sec pathway, pilus subunits interact with the periplasmic chaperone via a
conserved carboxy-terminal motif present on each of the pilus subunits. The chaperone
facilitates release of pilus subunits into the periplasm (Jones et al, 1997). Interaction with
the usher protein in the outer membrane triggers chaperone dissociation from the subunit,
allowing incorporation of the subunit into the pilus fiber. The usher provides a
translocation channel through the outer membrane for secretion of the pilus.
1.3.5. Type I Secretion
ATP binding cassette (ABC) transporters, found in eukaryotes and prokaryotes,
constitute a large superfamily of multi-subunit permeases that transport different
molecules (ions, amino acids, peptides, antibiotics, polysaccharides, proteins, etc) across
biological membranes. ABC transporters are classified as importers and exporters
depending on the direction of translocation of their substrate. The type I pathway is Sec
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independent and secretes proteins directly from the cytoplasm across the outer
membrane. Substrates of this pathway lack a cleavable amino-terminal signal sequence.
Instead, the substrates possess a carboxy-terminal amino acid secretion signal. The type I
export apparatus consists of two hydrophobic membrane spanning domains (MSDs)
associated with two cytoplasmic nucleotide binding domains (NBDs). The NBDs of ABC
transporters bind ATP and couple ATP hydrolysis to the transport process. The MSDs
consist of four to eight transmembrane α-helices forming a channel allowing the
translocation of the substrate through the membrane (Braibant et al, 2000).
An example of a type I ABC exporter is the secretion of hemolysin (HlyA) by
pathogenic E. coli. HlyA is a lipid-modified polypeptide with a domain that is composed
of 11-17 nine-amino-acid repeats. The repeat domains bind calcium and are thought to
interact with host cells, triggering HlyA insertion into the plasma membrane and leakage
of the cytoplasmic contents of target cells. TolC, the outer membrane protein for
hemolysin export, assembles as a trimeric complex in the outer membrane as a porin-like
β-barrel membrane domain with a carboxy-terminal hydrophilic region that extends into
the periplasm. TolC appears to be involved in several E. coli transport processes such as
the efflux of antibiotics, heavy metal ions, detergents and solvent (Thanabalu et al, 1998).
The E. coli genome encodes 57 ABC transporters, of which 44 are importers and 13 are
exporters. Gram-positive organisms also employ ABC transporters The B. subtilis
genome encodes 78 ABC transporters, of which 38 are importers and 40 are exporters.
1.3.6. Type II Secretion
The type II secretory pathway represents a third terminal branch of the Sec
pathway. This pathway is responsible for secretion of extracellular enzymes and toxins
by a wide variety of Gram-negative bacteria. Secretion across the outer membrane by the
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type II branch requires 12 to 16 accessory proteins (Pugsley et al, 1997). The type II
pathway includes two outer membrane components: GspD, an integral protein and GspS,
a small lipoprotein required in at least some type II systems for proper targeting and
insertion of GspD in the outer membrane. Type II substrates cross the inner membrane
via the Sec pathway followed by signal-sequence cleavage and protein folding in the
periplasm. The GspD forms a complex with the GspS lipoprotein and serves as a gated
channel for secretion of substrates to the cell surface. Most of components of the type II
pathway are associated with the inner membrane (GspC, GspF, GspM, GspL and GspO).
There are 5 pseudopilins (GspG, GspH, GspI, GspJ and GspK) each with a pilin signal
peptide that is cleaved by prepilin peptidase (GspO) during Sec-mediated translocation
across the plasma membrane. GspE is a cytoplasmic protein that localizes to the inner
membrane via interaction with GspL, contains a conserved ATP-binding motif and has
autokinase activity. GspE may regulate secretion or energize the secretion process (Lee
and Schneewind, 2001). The type II secretion machinery is responsible for secretion of
proteins across the outer membrane and assembly or retraction of type IV pili.
1.3.7. Type III Secretion
Type III secretion is activated by bacterial contact with host cells and is capable
of translocating antihost factors into the cytosol of target eukaryotic cells. Type III
secretion is Sec independent, may take place without a periplasmic intermediate, and
requires about 20 secretion components that assemble into a large structure that spans
bacterial membranes as well as the host cell membrane (Hueck, 1998). Secretion of
Yersinia outer proteins (Yops) by Yersinia spp. represents the typical type III export
pathway. There are 13 Yop proteins of Yersinia species (YopB, D, E, H, M, N, O, P, Q,
R, T, LcrV and Q) that do not share common peptide sequences and are secreted into the
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extracellular medium without post-translational modification or cleavage of the
polypeptide chain. The genes encoding Yops are located on a virulence plasmid. A
temperature shift to 37ºC, which occurs when bacteria enter the human body, induces
expression of the type III genes and assembly of the secretion machinery (Cornelis,
1998).Type III secretion is highly regulated with the first signal appearing to reside in the
mRNA which may target the RNA-ribosome complex to the type III machinery for
translation and secretion. The second Yop secretion signal serves as the binding site for
cytoplasmic chaperones termed Syc proteins and may target Yops to the type III
machinery for translocation into host cells. Most models for the mechanism of
translocation across the host cell membrane described a pore formation by YopB and
YopD proteins. Microscopic detection have revealed that YopE, H, M, O, P and T are
injected into eukaryotic cells; YopB, D and R are secreted into the extracellular space;
and YopQ is associated with the bacterial envelope (Cheng and Schneewind, 2000).
1.3.8. Type IV Secretion
Type IV transporters mobilize proteins and DNA either from bacteria to bacteria
or from bacteria to eukaryotic cells. The most common example of type IV secretion
pathway is the virB system of Agrobacterium tumefaciens that exports T-DNA across the
bacterial membranes and into plant cells, where the T-DNA integrates into the plant
genome (Zambryski, 1988).The virB locus consists of 11 genes, 10 of which (virB2 to
virB11) are critical for DNA transfer. Although virB1 is not essential, deletion of this
gene attenuates virulence and leads to a lower efficiency of DNA transfer (Berger and
Christie, 1994). The DNA transport system described for Agrobacterium tumefaciens is
very similar to a toxin transport system of Bordetella pertussis. This type IV pathway
consists of nine proteins required for the secretion of pertussis toxin across bacterial
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membranes. In general, type IV transporters contain 2 proteins (virB4 and virB11) with
nucleotide-binding motifs, these proteins might serve to signal the opening of a gate or
channel via kinase activity, or act as molecular chaperones in the assembly of the
transporter. Presently, very little is known about the series of events that occur during the
transport process.
1.4. Protein Secretion Mechanisms in Mycobacteria
Mycobacterial secreted proteins are translocated across the cytoplasmic
membrane, transported across the entire cell envelope and released into the extracellular
space. Exported proteins are those translocated across the cytoplasmic membrane and
either totally or partially associated with the cell envelope.
There is currently no evidence of autosecretion, type II, III or IV secretion system
in M. tuberculosis as described in E. coli and other Gram-negative bacteria. The
elucidation of the genome sequence of M. tuberculosis demonstrated that this organism
possesses all the genes required for Sec-dependent translocation of proteins; however, it
is not known how proteins are further exported through the cell wall of M. tuberculosis.
The cellular envelope of Mycobacterium species possesses characteristics of the cell
walls of both Gram-negative and Gram-positive bacteria. The pseudo-bilayer formed by
the cell wall-attached mycolic acids and outer layer lipids is similar to the outer
membrane of Gram-negative bacteria, whereas the arabinogalactan covalently attached to
the peptidoglycan is similar to the cell wall teichoic acids of some Gram-positive bacteria
(Brennan and Nikaido, 1995). Therefore, the mycobacterial cellular envelope with
mycolic acids and free lipids represents a formidable obstacle to protein secretion. Some
of the possible mechanisms that might be active to translocate this barrier are ABC
transporters, secretin-like proteins and porins (Braunstein and Belisle, 2000). Many
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putative ABC transporters are encoded by the M. tuberculosis genome; however, since
ABC transporters can import and export a wide range of molecules, it is difficult to
predict the transported substrate. Braibant, et al, 2000, reported that the genes encoding
the ABC transporters occupy about 2.5% of the genome of M. tuberculosis. Contrary to
E. coli but similar to B. subtilis, there is a relatively equal representation of exporting
systems versus importing systems in M. tuberculosis (16 importers versus 21 exporters).
Many of those exporting systems have been implicated in the export of anti-bacterial
drugs. In addition, there is one exporting system specific to M. tuberculosis and A.
tumefaciens that could be required for virulence and bacterial attachment to host cells
(Draper, 1998).
Several M. tuberculosis proteins identified in the cell wall or culture filtrate are
known to possess typical N-terminal signal sequences for translocation via the Secdependent pathway. The first evidence of a Sec-dependent pathway in mycobacteria was
the recognition of N-terminal signal peptides in the predicted amino acid sequences of
known M. tuberculosis exported and secreted proteins. The second indication that this
pathway exists in M. tuberculosis came from the identification of homologous secretion
factors (secA, secD, secE, secF and secY ) encoded by the M. tuberculosis genome
sequence (Cole et al, 1998).
Wiker et al, 2000, studied 28 M. tuberculosis secreted proteins and found the
median signal peptide length was 32 residues, the median n-region length was 9 amino
acids, the median h-region length was 16 amino-acids and the median c-region length
was 7 amino acids. In terms of overall amino acid composition, the n-region of M.
tuberculosis signal peptides is characterized by high arginine content (22%) and a relative
lower amount of lysine (6%). The arginine-rich n-regions are most likely explained by
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the high G+C content. Analysis of the preferred amino acids in the positions around the
cleavage site showed that the mycobacterial signal peptides generally fulfill the (-3,-1)
rule, with alanine in 19 of 28 signal peptides in position -3 and alanine in 23 of 28 in the
position -1.
The only Sec factor apparently lacking in M. tuberculosis is SecB, but this protein
has been found only in Gram-negative organisms.
Mycobacterium species possess all the genes required for Sec-dependent
translocation of proteins; however, M. tuberculosis encodes two homologs of SecA.
SecA1 and SecA2 contain ATP binding motifs but they are only 34% identical to each
other at the amino acid level. This sequence difference between the two SecA proteins
may reflect specific roles played by each in protein translocation (Braunstein et al, 2001).
Analysis of SecA nucleotide sequence data from different bacterial species has revealed a
high degree of conservation within the amino-terminus of the predicted protein sequence,
as well as a similarly conserved ATP binding motif. There are some differences in the
predicted carboxy-terminal regions, consistent with the likelihood that this portion of the
SecA protein interacts with the cytoplasmic membrane during the translocation process.
Owens et al, 2002, were able to build a chimeric form of SecA containing the aminoterminal end from M. tuberculosis and the carboxy-terminal end from E. coli to
complement the defective SecA protein in E. coli. The full-length M. tuberculosis secA
was unable to compensate for the temperature-sensitive (ts) defect, whereas the E. coli
mutant that had been transformed with the plasmid containing the chimeric secA gene
was able to grow at 42ºC. This experiment confirms that the N-terminal end of M.
tuberculosis SecA contains appropriate ATP binding sites and possesses sufficient
ATPase activity to compensate for the temperature-sensitive defect of the E. coli mutant.
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There is evidence of mechanisms to transport proteins with recognizable signal
sequences across the cytoplasmic membrane, however, it is unclear what determines the
extracellular release or retention in the cell wall (Braunstein and Belisle, 2000). The twinarginine pathway is Sec-independent and it is responsible for the translocation of folded
proteins across the cytoplasmic membrane. The possible presence of a twin-arginine
translocation system in M. tuberculosis is supported by the observation of homologs to
components of the twin-arginine system in E. coli (TatA, TatB, TatC and TatD).
Recently, Dilks et al, 2003, designed a program to predict the presence of Tat substrates
in bacterial genomes. TATFIND identified 31 open reading frames in M. tuberculosis and
9 in M. leprae, most of them are hypothetical proteins.
1.5. General Design of Studies to Identify M. leprae Secreted Proteins.
The standard approach for studying secretion in cultivable bacteria is to analyze
cell-free culture filtrates containing truly secreted proteins. This approach has
successfully identified approximately 200 secreted proteins in M. tuberculosis but has
been shown to contain cytoplasmic proteins that leaked into the culture filtrate through
normal bacterial lysis in culture (Sonnenberg and Belisle, 1997). While this approach has
been important in defining major groups of secreted proteins from M. tuberculosis and
other cultivable mycobacteria, it cannot be applied to studying ML proteins since
secreted proteins from M. leprae are lost during isolation of the bacilli from infected
animal tissues.
Comparative genomics has been another successful approach used to study
secretion. By identifying gene homologs in bacterial genomes known to be involved in
secretion pathways and identifying particular secretory peptide motifs in genes it is
possible to predict with good accuracy the destination of a selected protein. I have used
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this approach in my dissertation research by selecting known and predicted secreted
proteins of M. tuberculosis as a screen for homologous proteins in M. leprae. The ML
proteins selected by this approach were then reanalyzed for secretion motifs using
bioinformatic tools and finally examined for secretion following cloning into either E.
coli or M. smegmatis. Secretion of ML proteins was validated by observing the location
(cytoplasmic vs. extracellular) of a reporter protein (alkaline phosphatase) to which ML
genes were fused.
For the purposes of the studies outlined in my dissertation research I have not
attempted to distinguish between secreted and exported proteins. Rather, I have used
bioinformatic tools to predict those proteins of M. leprae that may be secreted via the
Sec-pathway and that may or may not remain associated with the bacterial cell wall.
Because M. leprae cannot be grown in vitro, it is impossible to validate the purely
extracellular location of proteins produced by M. leprae in culture. Therefore, protein
secretion in my studies was validated by genetic cloning of predicted secreted ML protein
genes into plasmid vectors containing reporter genes. The ML-reporter gene fusions
were transformed into either E. coli or M. smegmatis to evaluate protein secretion in
culture.
1.5.1.Comparative Genomics: M. tuberculosis vs. M. leprae
The complete genome sequence of M. leprae contains 3,268,203 base pairs (bp),
and has an average G+C content of 57.8% (Cole et al, 2001). These values are much
lower than those reported for the M. tuberculosis genome, which comprises 4,000
genes, 4,411,532 bp and 65.6% G+C (Cole et al, 1998). The apparent reason for the
large discrepancy in gene number has to do with M. leprae’s large number of
pseudogenes. The distribution of the 1,116 pseudogenes in M. leprae is essentially
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random and preliminary studies have suggested that some pseudogenes may produce
either partial or complete transcripts (Williams et al, 2003). Of the 1605 genes predicted
in M. leprae there are 1440 which are also found in M. tuberculosis and 165 genes that
have no orthologue in M. tuberculosis (Cole et al, 2001). The M. tuberculosis genome
was the first to be sequenced and revealed an organism with broad metabolic potential;
most anabolic pathways are present and it has many genes involved in lipid synthesis and
metabolism. By contrast, the M. leprae genome appears highly degenerate as defined by
deficiencies in genes for recombination, appears to have fewer lipolytic genes than M.
tuberculosis, lacks iron scavenging siderophores and is deficient in energy production.
The major protein families in M. leprae are involved in lipid or polyketide metabolism,
modification and synthesis of cell envelope components (methyl-transferases,
glycosyltransferases), transport processes (ABC transporters, MmpL proteins), or in gene
regulation (TetR, WhiB, two component system response regulators). While most of the
M. leprae genes have orthologues in M. tuberculosis, there are several that appear to be
unique and may have novel activities. These include hypothetical proteins, inorganic
pyrophosphatase, prolyl-tRNA synthetase, uridine phosphorylase, adenylate cyclase,
cytochrome P450 (Cole et al, 2001).
Examination of the genome sequence of the leprosy bacillus provides possible
explanations for some of M. leprae's unique properties. M. leprae has the longest
doubling time of any known bacteria and cannot be grown in culture, both properties of
which are potentially due to an extreme case of gene loss through reductive evolution.
Less than half of the genome contains functional genes, with many pseudogenes showing
functional counterparts in Mycobacterium tuberculosis. Cole et al, 2001, made the
assumption that the genomes of M. leprae and M. tuberculosis were once topologically
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equivalent and aproximately 4.4 Mb in size, as is the case for many other slow-growing
mycobacteria. Extensive downsizing must have occurred during evolution of the leprosy
bacillus since its genome is less than 75% of the size of that of M. tuberculosis. Since
diverging from the last common mycobacterial ancestor, the leprosy bacillus may have
lost over 2000 genes, and reductive evolution may have defined the minimal gene set for
a pathogenic mycobacterium. Based on these data it is reasonable to expect a reduced
number of secreted proteins from M. leprae as compared to M. tuberculosis. For my
study I used a total of 204 M. tuberculosis protein sequences previously characterized as
secreted to search for homologs in the M. leprae genome.
1.5.2.Bioinformatics
Bioinformatics is the field of study in which computer algorithms are used to
predict properties of proteins. I utilized bioinformatics tools to predict protein location
(e.g. cytoplasmic, cell membrane, secreted) of M. leprae proteins. The first tool used
predicted signal peptides which involves two tasks: 1) given that a sequence has a signal
peptide, locate the cleavage site and, 2) discriminate between secretory proteins with
signal peptides and non-secretory proteins. Nielsen et al, 1997, have developed a
combined neural network approach to the recognition of signal peptides and their
cleavage sites, using one network to recognize the cleavage site and another network to
distinguish between signal peptides and non-signal peptides. It is called SignalP. Nielsen
et al used a list of known secreted proteins taken from SWISS-PROT and divided them
into prokaryotic and eukaryotic entries. The prokaryotic data sets were further divided
into Gram-positive eubacteria and Gram-negative eubacteria.
The output from the signal peptide/non-signal peptide networks, the S score, can
be interpreted as an estimate of the probability of the amino acid position belonging to a
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signal peptide, while the output from the cleavage site/non-cleavage site networks, the Cscore, can be interpreted as an estimate of the probability of the amino acid position being
the first in the mature protein. If there are several C-score peaks of comparable strength,
the true cleavage site may often be found by inspecting the S-score curve in order to see
which of the C-score peaks coincides best with the transition from the signal peptide to
the non-signal peptide region. In order to formalize this and improve the prediction,
Nielsen et al defined Y as the geometric average of the C-scores and a smoothed
derivative of the S-score. They found the best discriminator between signal peptides and
non-secretory proteins to be the average of the S-score in the predicted signal peptide
region. If this value, the mean S-score, is greater than 0.5, they predict the sequence in
question to be a signal peptide.
Signal anchors often have sites similar to signal peptide cleavage sites after their
hydrophobic (transmembrane) region; therefore, a prediction method can easily be
expected to mistake signal anchors for peptides. A similar method to predict the location
and orientation of transmembrane alpha helices based on a hidden Markov model
(TMHMM) was designed by Sonnhammer et al, 1998. A model for a transmembrane
orientation consists of 3 states: one for inside loops, one for transmembrane regions and
one for outside loops. Each state has an associated probability distribution over the 20
amino acids characterizing the variability of amino acids in the region it models. An
analysis of the performance of different programs for the prediction of transmembrane
regions in proteins by Moller et al, 2001, showed that TMHMM is currently the best
performing transmembrane prediction program. Eighty-five percent of proteins analyzed
with TMHMM have their membrane spanning regions correctly predicted. When the
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polarity of their integration into the membrane is included, the number of correct
predictions is reduced to 70%.
Gomez et al, 2000, used two algorithms, SignalP and SPScan to predict the
location of 3,924 M. tuberculosis proteins. Cutoff values for the computer predictions
were chosen on the basis of scores assigned to nine known secreted proteins of M.
tuberculosis that contain a signal peptide. 208 proteins that scored above the cutoff with
both programs were analyzed with TMpred and PrositeScan and sorted in 3 groups: 52
proteins were classified as most likely secreted, 25 proteins as transmembrane proteins
and 16 as lipoproteins. Ten proteins were chosen at random for cloning into a phoA
fusion vector and screened for alkaline phosphatase activity. The computer predictions
were confirmed in 90% (9 of 10) of the putatively secreted proteins tested by E. coli
phoA gene fusion methods.
A disadvantage of the computer-based approach is that it is limited to only those
proteins secreted via the general secretory pathway. While many secreted antigens of
Mycobacterium tuberculosis fall into this category, the presence in culture filtrates of
proteins lacking secretory signal peptides suggest the existence of other mechanisms of
protein secretion in M. tuberculosis.
In this study, I used a bioinformatic strategy to predict M. leprae secreted
proteins. Two different programs (SignalP and TMHMM) were used to identify proteins
having secretory signal peptides and appropriate membrane attachment domain for
secretion.
1.5.3.Validation of Protein Secretion
Proteins released by Mycobacterium tuberculosis into the extracellular
environment have been the focus of investigation to identify antigens that may induce
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protective immunity or elicit immune responses of diagnostic value. M. tuberculosis
culture filtrates have been used to identify mycobacterial proteins that induce protection
against M. tuberculosis infection in animal models (Collins et al, 1988; Hubbard et al,
1992; Freer et al, 1998; Weldingh et al, 1998). Culture filtrates have provided a rich
array of secreted proteins for study from M. tuberculosis and M. bovis, however, because
M. leprae cannot be grown in vitro similar culture fractions are not available for study.
Andersen et al, 1991, classified the proteins present in culture filtrates of M. tuberculosis
into three major groups: extracellular proteins that accumulate in large quantities in the
medium but are present only in trace amounts in the intact bacilli, secreted proteins that
are gradually released during growth of the bacilli and cytoplasmic proteins released from
dead bacteria during the late logarithmic growth phase. Wiker et al, 1991, developed an
index for individual mycobacterial antigens expressing the ratio between the amount of
each antigen in culture fluid and in sonicate preparations. There was good agreement
between signal sequences and measured index.
More recently, genetic approaches have been applied to identify secreted proteins
of M. tuberculosis. These studies involve screening libraries composed of M.
tuberculosis-reporter gene fusions. By constructing protein fusions with these reporters
and assaying for activity in colonies growing on plates, the location (intracellular vs.
extracellular) of a given protein can be determined. Hoffman and Wright, 1985,
constructed a fusion vector encoding a protein with a modified form of the phoA gene, an
easily assayable enzyme normally located in the periplasm of E. coli

K-12. PhoA can

be detected even at low levels in bacterial colonies by use of chromogenic substrate 5bromo-4-chloro-3-indolyl phosphate (XP); however, its activity is absolutely dependent
upon secretion from the cytoplasm. Hoffman and Wright altered the phoA gene,
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removing its promoter region, ribosome binding site and the complete signal sequence
encoding region, and showed that the phoA gene can function as a reporter for secreted
proteins in E. coli. PhoA is also known to function as a reporter for exported and secreted
proteins in M. smegmatis (Timm et al, 1994). Lim et al, 1995, screened M. tuberculosis
DNA-phoA fusion libraries respectively by using a phoA reporter shuttle plasmid
pJEM11 which replicates in E. coli and M. smegmatis. They found 12 different inserts
allowing PhoA expression. Some of the known M. tuberculosis proteins identified were
the 19kDa lipoprotein, the 28kDa (erp) protein and an enzyme implicated in the
biosynthetic pathway of fatty acids. Carroll et al, 2000, used the same approach to study
M. avium secreted proteins. They isolated 100 PhoA recombinants and 15 of these were
sequenced, most of them exhibited high degree of homology with known M. tuberculosis
and M. leprae sequences corresponding to phosphate permeases, cutinases,
glycosyltransferases, multicopper oxidases and putative invasins. Wiker et al, 2000, used
computational algorithms in combination with gene fusions to identify secreted proteins,
membrane proteins and lipoproteins of M. tuberculosis. The computer-algorithms were
used to predict the subset of M. tuberculosis genes that encode exported proteins. Of the
34 genes identified by the phoA method, 22 were classified to encode potential soluble
secreted proteins. Among these were some known antigens (fbpB and C, mpt53, mpt64,
mtb12) as well as 14 novel secreted proteins. Six of the remaining 12 genes were
predicted to encode membrane lipoproteins and an additional six to encode integral
membrane proteins.
In this study, I used a genetic approach to validate secretion of proteins predicted
for secretion by constructing alkaline phosphatase-ML gene fusions. Both E. coli and M.
smegmatis were selected as surrogate host to validate secretion of M. leprae proteins
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because the Sec dependent pathway is similar to M. tuberculosis and M. leprae and these
two organisms were used before to study secretion in M. tuberculosis.
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CHAPTER 2
BIOINFORMATICS
2.1.Introduction
Bioinformatics is a newly emerging interdisciplinary research area which may be
defined as the interface between biological and computational sciences. One of the subdisciplines of bioinformatics is the development of new algorithms and statistics to assess
relationships among members of large data sets. As a consequence of the large amount of
data produced in the field of molecular biology, most of the current bioinformatics
projects address structural and functional aspects of genes and proteins. With the
increasing number of bacterial genomes being sequenced demands are being made upon
workers to develop new methods to define proteomes of these organisms.
One group of proteins of great importance is the secreted proteins, given their
dominant immunogenicity and role in pathogenesis (Closs et al, 1980; Harboe and Nagai,
1984; Wiker et al, 1986). The large majority of these proteins possess an amino-terminal
signal sequence that mediates their membrane translocation via the Sec-dependent
general export pathway. Following translocation, cleavage of the signal peptide by a
signal peptidase releases the mature protein, provided there are not additional membranespanning segments (Murphy and Beckwith, 1987). Three distinct regions comprise the Nterminal signal sequence; the charged N-terminus (n-region), the hydrophobic core (hregion), and the C-terminal cleavage domain (c-region) (von Heijne, 1985). Secreted
proteins that follow the Sec-dependent general export pathway can be predicted using
computer algorithms.
Analysis of Mycobacterium tuberculosis proteins resulted in the observation that
the culture filtrate of in vitro-grown bacilli contains the majority of dominant antigens
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(Abou-Zeid et al, 1988; Collins et al, 1988; Hubbard et al, 1992). This procedure cannot
be applied to M. leprae because the bacilli do not grow in artificial media and secreted
proteins are lost during isolation of bacilli from tissues. To search for secreted proteins of
M. leprae, we have compared known and putatively secreted protein sequences of M.
tuberculosis with the M. leprae genome. Gomez, et al, 2000, identified 52 M.
tuberculosis proteins by computer-based analysis as most likely secreted. They used
SignalP and SPScan to predict potential signal peptides, and TMpred to predict the
presence of membrane-anchoring sequences. This approach identified novel secreted
proteins that can be characterized for their potential for immunological diagnosis of
tuberculosis or vaccine design. In this study, I used bioinformatic tools to predict
M.leprae secreted proteins. Two different programs were used to identify proteins
having secretory signal peptides but lacking additional membrane attachment domains:
-

SignalP, Nielsen, et al, 1997, predicts the presence and location of signal
peptide cleavage sites in amino acid sequences. The method incorporates a
prediction of cleavage sites and a signal peptide/non-signal peptide prediction
based on a combination of Neural Networks and Hidden Markov models.

-

Transmembrane Helix Markov model (TMHMM), Sonnhammer, et al, 1998,
predicts the location and orientation of transmembrane helices (TMH) in
protein sequences. The number and location of TMH predicts whether a
protein is secreted or anchored in the membrane.

2.2.Materials and Methods
2.2.1.Genome Database
M. tuberculosis and M. leprae DNA and protein sequences were obtained from
the Sanger Centre and the National Center for Biotechnology Information (NCBI).
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2.2.2.Amino Acid Comparisons of M. leprae and M. tuberculosis Proteins
Comparisons between M. tuberculosis and M. leprae completed genomes were
restricted to amino acid sequences and were performed using BLASTP (protein vs.
protein) server from the Sanger Centre. A total of 204 M. tuberculosis protein sequences
defined as putatively secreted (Sanger Centre) or previously characterized as secreted
(Gomez et al, 2000 and Wiker et al, 2000) were used to search for homologs in the M.
leprae genome. Each M. tuberculosis known or putatively secreted protein served as a
query sequence against the entire database of M. leprae. Final selection of ML proteins
was restricted to proteins showing more than 40% identity with an M. tuberculosis
protein.
2.2.3.Computer-based Algorithms
SignalP (www.cbs.dtu.dk/services/SignalP-2.0)
The SignalP World Wide Web server predicts the presence and location of signal
peptide cleavage sites in amino acid sequences from different organisms: Gram-positive
prokaryotes, Gram-negative prokaryotes, and eukaryotes. The method incorporates a
prediction of cleavage sites and a signal peptide/non-signal peptide prediction based on a
combination of several artificial neural networks. SignalP V2.0 comprises two signal
peptide prediction methods, SignalP-NN (based on neural networks, corresponding to
SignalP V1.1) and SignalP-HMM (based on hidden Markov models). The Neural
Networks are based on “learning” by adjusting the weights in the network until its
performance on the training set is acceptable. For example, known secreted proteins are
used as database to train the neural network to recognize unknown secreted proteins.
The Hidden Markov Models use general statistical modeling technique for linear
problems like sequences or time series and have been widely used in speech recognition
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applications for 20 years. An HMM for proteins consists of a number of states that are
connected by transition probabilities. Associated with each state is a distribution over the
20 amino acids. The SignalP server will return 3 different scores between 0 and 1 for
each position in the sequence: C, S and Y. In addition, the maximal Y-score, maximal Sscore and mean S-score values are given for the entire sequence. If the mean S-score is
equal or greater than 0.5, SignalP predicts the sequence in question to be a signal peptide.
-

C-score (raw cleavage site score): The output score from networks trained to
recognize cleavage sites vs. other sequence positions.

-

S-score (signal peptide score): The output score from networks trained to
recognize signal peptide vs. non-signal peptide positions.

-

Y-score (combined cleavage site score): The prediction of cleavage site location
is optimized by observing where the C-score is high and the S-score changes from
high to a low value. The Y-score formalizes this by combining the height of the
C-score with the slope of the S-score.

Up to 70 amino acid long N-terminal sequences were analyzed in my dataset using
the program trained for Gram-positive organisms. If a sequence was predicted to have a
signal peptide, the cleavage site was predicted to be immediately before the position with
the maximal Y-score. Discrimination between signal peptides and non-secretory proteins
was done by using the mean value of the S-score, averaged from position 1 to the most
likely cleavage site.
TMHMM (www.cbs.dtu.dk/services/TMHMM-2.0)
Transmembrane Hidden Markov Model (TMHMM) is a method to predict the
location and orientation of transmembrane helices in protein sequences, it is based on a
hidden Markov model. The basic principle is to define a set of states, each corresponding
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to a region or specific site in the proteins. In the simplest case, a model for a
transmembrane protein may consist of three states: one for inside loops, one for
transmembrane regions and one for outside loops. Positively charged residues are
predominantly found in loops on the cytoplasmic side. Most transmembrane α helices are
encoded by a long stretch of hydrophobic residues, that are suitable for hydrophobic
interactions with lipids. Many signal peptides also have one hydrophobic region. The
number and location of transmembrane domains predicts whether the protein is secreted
or anchored in the membrane. The algorithm provides information about the number of
transmembrane domains along the amino acid sequence and also predicts an extracellular
or intracellular location of the protein. For example, there are 3 main locations of a
residue: in the transmembrane helix core (in the hydrophobic tail region of the
membrane), in the transmembrane helix caps (in head region of the membrane), and in
loops. A typical secreted protein will show an N-terminal small intracellular portion
followed by a transmembrane helix (20 to 40 amino acid long) and the remaining
sequence located extracellularly. Some sequences have no transmembrane helix and they
are located either extracellularly or intracellularly.
2.2.4.Comparisons between M. tuberculosis and M. leprae Sequences
Pairwise alignments of amino acid sequences from signal sequences and mature
proteins were performed using OmigaTM 2.0 (Oxford Molecular Ltd., www.gcg.com).
Identification of N-region (positively-charged amino acids), H-region (hydrophobic
amino acids) and C-region (signal peptidase recognition site) was based on SignalP.
Transmembrane domains were predicted using TMHMM.
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2.3.Results
A total of 204 putatively secreted or known to be secreted proteins of M.
tuberculosis were used to identify homologous amino acid sequences in M. leprae. The
BLASTP analysis showed that 52 of the 204 M. tuberculosis proteins had no match to
proteins in M. leprae. Thirty-eight M. tuberculosis proteins were represented by
pseudogenes or inactive reading frames in the M. leprae genome and 114 M. tuberculosis
proteins showed amino acid identity of greater than or equal to 40% with proteins in M.
leprae. These 114 M. leprae proteins were analyzed to predict secretion with 2 computer
algorithms: SignalP to predict the presence and location of signal sequences, and
TMHMM to predict the location and orientation of transmembrane helices in protein
sequences. Analysis with SignalP identified 32 proteins with a mean S score ≥ 0.5 (Table
1). These 32 protein sequences were analyzed with TMHMM resulting in the selection
of 24 sequences designated with high probability of being secreted based on the presence
of 1 or zero transmembrane domains in proper orientation with the predicted signal
sequence (Table 1, gene name in bold letters). The remaining 8 sequences were predicted
to be either transmembrane or intracellular proteins (Table 1). Nineteen proteins
(ML0091, ML0097, ML0098, ML0620, ML0885, ML1339, ML1417, ML1633,
ML1811, ML2028, ML2055, ML2331, ML2380, ML2450, ML2522, ML2569A,
ML2591, ML2598 and ML2659) from a total of 24 putatively secreted proteins had a
typical N-terminal intracellular sequence followed by a transmembrane domain and good
cleavage site prediction. The remaining five sequences (ML0715, ML1812, ML1923,
ML2274 and ML2569) showed 0 transmembrane domains and were predicted by
TMHMM to be secreted based on amino acid composition (Table 1) as well.
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Table 1: M. leprae proteins selected for secretion by SignalP and TMHMM
Gene name
ML0041
ML0091
ML0097
ML0098
ML0175
ML0486
ML0575
ML0620
ML0715
ML0885
ML1010
ML1214
ML1339
ML1417
ML1537
ML1633
ML1811
ML1812
ML1923
ML2028
ML2055
ML2274
ML2331
ML2380
ML2450

1

MT
Homolog*
Rv3883c
erp
fbpA
fbpC1
Rv0982
Rv2588c
Rv0849
mtb12
lpqC
Rv2190c
bcpB
Rv1566c
Rv2672
Rv2289
Rv1797
Rv2223c
Rv1478
Rv1477
lpqF
fbpB
modD
Rv0559c
Rv3717
Rv0455c
Rv0479c

2

Signal peptidase
motif
Ala-Leu-Ala
Ala-Ile-Ala
Ala-Glu-Ala
Ala-Lys-Ala
Ile-Ser-Ala
Ala-Ser-Arg
Cys-Leu-Ala
Ala-Pro-Ala
Val-Ser-Ala
Ala-Met-Ala
His-Gly-Ala
Ala-Tyr-Ala
Ser-Gly-Ala
Ala-Glu-Ala
Trp-Gln-Ala
Val-Arg-Val
Ala-Thr-Ala
Ala-Thr-Ala
Ala-His-Ser
Ala-Gly-Gly
Ala-Ala-Ala
Ala-Leu-Ala
Ala-Val-Ala
Ala-Val-Ala
Ile-Gly-Ala

3

C site

21-22
22-23
42-43
36-37
49-50
23-24
39-40
52-53
26-27
37-38
24-25
26-27
33-34
25-26
39-40
56-57
31-32
39-40
37-38
32-33
37-38
25-26
31-32
30-31
26-27

4

SignalPmean S
0.92
0.95
0.69
0.88
0.96
0.74
0.75
0.5
0.73
0.79
0.5
0.76
0.81
0.83
0.8
0.56
0.85
0.91
0.76
0.74
0.63
0.78
0.89
0.84
0.76
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5

Predicted TMs

1 (417-439)
1 (9-31)
1 (13-35)
1 (7-29)
2 (30-52 and 162-84)
1 (4-21)
2 (5-27 and 42-64)
1 (5-27)
0
1 (12-34)
0
1 (4-26)
1 (13-35)
1 (5-23)
2 (7-29 and 44-66)
1 (30-52)
1 (7-29)
0
0
1 (13-35)
1 (13-35)
0
1 (13-32)
1 (7-29)
1 (7-29)

6

Location

Transmembrane
Secreted
Secreted
Secreted
Transmembrane
Intracellular
Transmembrane
Secreted
Secreted
Secreted
Intracellular
Intracellular
Secreted
Secreted
Transmembrane
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
(Table continued)

ML2522
ML2569
ML2569A
ML2591
ML2598
ML2659
ML2664

Rv0309
Rv0237
Rv0236A
mce1C
Rv0178
Rv0125
Rv0116c

Ala-Gly-Ala
Ala-Gln-Ala
Val-Gln-Gln
Leu-Phe-Ala
Ala-Gly-Ala
Gly-Ser-Ala
Ser-Val-Ala

30-31
27-28
32-33
38-39
39-40
32-33
28-29

0.95
0.76
0.77
0.56
0.64
0.87
0.69

1 (5-27)
0
1 (7-29)
1 (13-35)
1 (20-42)
1 (13-35)
2 (7-29 and 39-58)

Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Transmembrane

1 Gene names for proteins from MT that have 50% or greater amino acid identity with matched ML protein
2 The signal peptidase motif represents the site recognized by the signal peptidase. Ala-X-Ala is the conserved motif for signal
peptidase.
3 C site represents the amino acid position at which the signal peptidase cleavage site was predicted
4 This value represents the mean of signal peptide scores.
5 TM represents number of transmembrane domains for each protein with amino acid position given in parenthesis.
6 Predicted location of ML proteins based on analysis by SignalP and TMHMM algorithms
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A group of 8 proteins were identified as most likely not secreted based on
physical characteristics including amino acid composition and transmembrane domains.
ML1010 (no transmembrane domain), ML0486 and 1214 (1 N-terminal transmembrane
domain each) were composed of amino acid seen primarily in proteins located
intracellularly. Analysis of ML0041 showed 1 C-terminal transmembrane domain with
the remainder of the protein predicted to be located extracellularly. Four sequences
(ML0175, ML0575, ML1537 and ML2664) had 2 transmembrane domains and,
therefore, were classified as putative membrane proteins.
The Ala-X-Ala motif for the signal peptidase was conserved only in 15 of 24
sequences that were predicted to be secreted by SignalP and TMHMM (Table 1).
Gly or Ser in position -1 was found in 2 sequences and Val or Ser in position -3 was
found in 5 sequences as alternative signal peptidase recognition sites (von Heijne, 1983).
Only 1 sequence (ML2569A) from a total of 24 had an amino acid different from Ala,
Gly or Ser in position -1 and 3 sequences (ML2450, ML2591 and ML2659) had an
amino acid different from Ala, Val, Ser or Thr in position -3. The signal sequences
ranged in size from 21 to 56 amino acids (Table 1).
A comparison between each of the 24 M. leprae proteins and their M. tuberculosis
counterparts was performed using the amino acid alignment program from Omiga 2.0.
Fifteen M. leprae proteins showed 50% or greater amino acid homology for the mature
protein (not including signal sequence) with the corresponding M. tuberculosis sequences
(Table 2). Fourteen of 15 alignments showed that the amino acid identity between
mature proteins from M. leprae and M. tuberculosis homologs was considerably higher
than the amino acid identity between signal sequences (Table 2).
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Table 2: Comparison of the signal sequences and the mature proteins from
Mycobacterium leprae and Mycobacterim tuberculosis predicted secreted proteins.
Gene
name
ML0091

1

Length

2

236

MT
homolog
erp

ML0097

330

ML0098

Length

3

4

284

Signal seq.
(%Id/%Sim)
73
86

Mature prot.
(%Id /%Sim)
55
67

fbpA

338

63

74

86

92

301

fbpC1

299

44

69

82

89

ML0620

167

mtb12

168

40

50

58

70

ML0715

304

lpqC

304

58

62

73

81

ML0885

374

2190c

385

27

43

60

72

ML1811

241

1478

241

55

68

80

85

ML1812

479

1477

472

72

79

79

87

ML1923

454

lpqF

452

44

47

82

84

ML2028

327

fbpB

325

67

77

85

91

ML2274

112

559c

112

64

76

71

82

ML2331

256

3717

241

58

74

77

84

ML2380

153

455c

148

57

63

68

76

ML2569

387

237

388

63

74

74

82

ML2591

519

mce1C

515

71

82

73

83

1 Length of protein in amino acids.
2 MT protein that has 50% or greater amino acid identity with matched ML protein.
3 Comparison alignments between ML and MT signal sequences. Percentages of amino
acid identities and similarities are indicated for each comparison.
4 Comparison alignments between ML and MT mature proteins (signal sequences
removed). Percentages of identities and similarities are indicated for each comparison.
Signal sequences from M. leprae and M. tuberculosis were aligned to compare the length
and percentage of arginine in the N-region. Six out of 15 pairs comparisons showed
identical arginine content in the N-region for M. leprae and M. tuberculosis signal
sequences (Figure 2). Two signal sequences (ML0620 and ML2274) showed no arginine
in the signal sequence as did their MT homologs. The remaining ML signal sequences
ranged in arginine content from 10% to 37.5%. The mean of the arginine content in the
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N-region was 22% for M. tuberculosis sequences and 19% for M. leprae sequences

% Sequence identity (similarity)

(Figure 2).

90
80
70
60
50
40
30
20
10
0
Signal seq Id Signal seq
Sim

Mature prot Mature prot
Id
Sim

Figure 1: Comparison of amino acid sequence identity and similarity between ML
and MT proteins.
Signal sequence

Percentage of
arginine (R) in
the N-region

ML0091
Erp

MPNRRRCKLSTAISTVATLAIA
MPNRRRRKLSTAMSAVAALAVA

37.5%
50%

ML0097
fbpA

MKFVDRFRGAVAGMLRRLVVEAMGVALLSALIGVVGSAPAEA 23.5%
MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGA 23.5%

ML0098
fbpC1

MRGLSAVVRVLCVAALAVGVFAAAVLLAGTAGNAKA
MKGRSALLRALWIAALSFGLGGVAVAAEPTAKA

22%
22%

ML0620
Rv2376c

MTMKSIATYAALAIIGAAV
MKMVKSIAAGLTAAAAIGAAA

0%
0%

Figure 2: Comparison alignments of 15 signal sequences of predicted secreted
proteins in M. leprae and M. tuberculosis.
N-region in blue, hydrophobic region in black, cleavage site in red and lipoprotein motif
in green. Identification of N-region (positively-charged amino acids), H-region
(hydrophobic amino acids) and C-region (signal peptidase recognition site) was based on
TMHMM prediction. Color printer needed to reproduce figure accurately (Figure
continued).
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ML0715
lpqC

MNVARWLASVVLAVCLAGCVGRQVSA
MPWARMLSLIVLMVCLAGCGGDQLLA

17%
17%

ML0885
Rv2190c

MRLGCKHPVVRLIAHFVVGTLVGFAVLSRFFVATAMA
MRLDQRWLIARVIMRSAIGFFASFTVSSGVLAANVLA

13%
27%

ML1811
Rv1478

MRHKNFRLINLAGLTAMVAGLIIVVTIPATA
MRHTRFHPIKLAWITAVVAGLMVGVATPADA

20%
20%

ML1812
Rv1477

MKRPRRGSVSRPTARFVRPAIPSLVSAALLVSLPVLATA
MRRNRRGSPARPAARFVRPAIPSALSVALLVCTPGLATA

33%
40%

ML1923
lpqF

MPQPARRTNQRPPRHRTVALAATAALVVTMAPGCAHS
MGPARLHNRRAGRRMLALSAAAALIVALASGCSSAPTPSANA

31%
36%

ML2028
fbpB

MIDVSGKIRAWGRWLLVGAAATLPSLISLAGG
MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLA

14%
29%

ML2274
Rv0559c

MKGTGLAANVAMAAAATVLAAPALA
MKGTKLAVVVGMTVAAVSLAAPAQA

0%
0%

ML2331
Rv3717

MNTRVSLRIGFRMVVGLLVAALTTITPTAVA
MIVGVLVAAATPIISSASATPANIAGMVVFI

25%
0%

ML2380
Rv0455c

MSRLSTSLCKGAVFLVFGIIPVAFPTTAVA
MSRLSSILRAGAAFLVLGIAAATFPQSAAA

10%
20%

ML2569
lpqI

MAFPRTLIVLAAASALVVTCGHDVAQA
MAFPRTLAILAAAAALVVACSHGG

17%
17%

ML2591
mce1C

MRTLELPNRLRSGLIGVLVVLLIIGVGQSFTSVPILFA
MRTLEPPNRMRIGLMGIVVALLVVAVGQSFTSVPMLFA

27%
27%

2.4.Discussion
204 M. tuberculosis known secreted and putatively secreted proteins were used to
search for homologous M. leprae proteins using bioinformatic tools. Fifty-two M.
tuberculosis proteins did not show any matches with the M. leprae genome while 38 M.
tuberculosis proteins had homologies with pseudogenes in the M. leprae genome. The
large number of pseudogenes was not unexpected based on the previously reported
relatively low number of functional genes and the high number of pseudogenes in M.
leprae (Cole et al, 2001) (Table 3).
44

Table 3: Comparison of M. leprae and M. tuberculosis genome features.
Feature
Genome size (bp)
G+C%
Protein-coding genes
Pseudogenes
Predicted secreted proteins
G+C% secreted prot. genes
*Gomez et al, 2000.

M. leprae
3,268,203
57.79
1,604
1,116
24
60.5

M. tuberculosis
4,411,532
65.61
3,959
6
52*
66

One hundred and fourteen M. leprae proteins were identified using the M.
tuberculosis protein homolog search. Analysis with SignalP and TMHMM identified 24
M. leprae proteins meeting the criteria for secretion. Five of these genes encode
authentic secreted proteins in M. tuberculosis (fbpA, B and C, erp and mtb12) supporting
the validity of this approach for selecting secreted proteins from M. leprae.
TMHMM is currently one of the best performing transmembrane prediction
programs and is especially good at reliably distinguishing between soluble intracellular
and transmembrane proteins (Moller et al, 2001). Eighty-five percent of biochemically
characterized membrane proteins analyzed with TMHMM by Moller et al, 2001, were
predicted correctly. The number of predicted secreted proteins for M. tuberculosis and
M. leprae (Table 3) resulting from the computer-based approach appears low compared
to the 200 plus M. tuberculosis proteins found in culture filtrates. However, the low
number of predicted ML secreted proteins does correlates with the fact that the
algorithms used in this study detect only those proteins secreted via the Sec pathway.
While many secreted antigens of M. tuberculosis are translocated via the Sec pathway,
the presence in culture filtrates of proteins lacking secretory signal peptides (ex.; ESAT6, sodA, glnA and katG ) suggests the existence of other mechanisms of protein secretion
in Mycobacterium spp. For example, ESAT-6 secreted antigen, which is present in M.
tuberculosis, virulent M. bovis and has been recently identified in M. leprae (Spencer et
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al, 2002), is a member of a family of 100-amino acid proteins with sequence similarity
focused on a central WXG motif. Members of this family have been identified in several
Gram-positive pathogens (e.g.; S. aureus and B. anthracis) and may be components of a
surface-located secretion apparatus. By analogy with Gram-negative mechanisms of
secretion, this apparatus might be assembled only under specific conditions (e.g., contact
with host cell) (Pallen, 2002). Since M. leprae has homologs of ESAT-6, sodA and glnA,
this secretory system may also be functional in M. leprae adding to its potential number
of total secreted proteins.
Four of the 24 M. leprae proteins predicted to be secreted using SignalP and
TMHMM were previously described M. tuberculosis and M. leprae proteins: ML0097
fibronectin-binding protein (fbpA), ML2028 (fbpB) and ML0098 (fbpC); and ML2591
(mce1C), one of the genes of the mammalian cell entry operon. The fibronectin-binding
proteins (fbpA, fbpB and fbpC) stimulate the uptake of mycobacterial bacilli by human
macrophages by interacting with the gelatin binding site of human fibronectin (AbouZeid et al, 1988) and also have cell wall mycolyltransferase activity (Belisle, et al, 1997).
Arruda et al, 1993, described a DNA fragment of M. tuberculosis that conferred
to a non-pathogenic E. coli strain the ability to gain entry into mammalian cells and to
survive inside macrophages. The mammalian cell entry (mce) gene was termed mce1.
Analysis of the M. tuberculosis genome revealed four copies of mce, situated in operons
of 8 genes each.
The erp gene known as exported repetitive protein was identified in M. bovis
culture supernatants by Western blot (Bigi et al, 1995). Erp is a secreted antigen from M.
tuberculosis required for virulence (Berthet et al, 1998). Together the fibronectin-binding
proteins (fbpA, fbpB and fbpC), mce1C and erp represent secreted virulence factors of M.
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tuberculosis and M. bovis. My study shows that they are also predicted to be secreted in
M. leprae, however, further studies will be necessary to confirm whether they represent
virulence factors in M. leprae.
The generally accepted Ala-X-Ala motif for signal peptidase was conserved in 15
of 24 ML sequences that were predicted to be secreted by SignalP and TMHMM (Table
1). Gly or Ser in position -1 was found in 2 sequences and Val or Ser in position -3 was
found in 5 sequences as alternative signal peptidase recognition sites (Saleh, et al, 2001).
Only 1 sequence (ML2569A) from a total of 24 had an amino acid different from Ala,
Gly or Ser in position -1, and 3 sequences (ML2450, ML2591 and ML2659) had an
amino acid different from Ala, Val, Ser or Thr in position -3 (Table 1). These results are
in agreement with Wiker, et al, 2000, who showed that M. leprae signal peptides have
similar cleavage site motifs to those found in M. tuberculosis signal peptides. Four
sequences from a total of 24 do not fit the model described by Saleh et al, 2001. It is
possible that signal peptidases from M. leprae may accept amino acids not present in the
conventional model described for cleavage site motif.
Fifteen M. leprae proteins showed 50% or greater homology for the mature
protein (not including signal sequence) with the corresponding M. tuberculosis sequences
meeting my requirement for further analysis (Table 2). Fourteen of these alignments
showed that the homology between mature proteins is considerably higher than the
homology between signal sequences. The mean identity between ML and MT homologs
for mature proteins was 73.5% and only 57% for signal sequences. These data correlate
with the fact that signal peptides from Gram-positive bacteria are considerably longer and
more variable than those from other organisms (Nielsen et al, 1997). Harboe and Wiker,
1999, searched for secreted proteins from M. leprae by comparing DNA sequences from
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M. tuberculosis and M. leprae prior to the completion of the ML genome. They
identified only 10 sequences (fbpA, fbpB, fbpC, mpt32, mpt51, erp, mtc28, mtb12,
Rv3354 and Rv0526) with high homology between M. tuberculosis and M. leprae. My
study showed that 5 of 10 sequences predicted to be secreted by Harboe and Wiker (fbpA,
fbpB, fbpC, erp and mtb12) plus 19 other proteins were predicted to be secreted using the
criteria set for secretion. Harboe and Wiker’s analysis was performed prior to the
completion of the M leprae genome leaving their analysis incomplete. In addition, they
used an older version of SignalP and no algorithm to predict the presence of
transmembrane domains. Nevertheless, their conclusions and my results are in
agreement. For example, they reported that the genomic organization of genes for
secreted proteins was similar in M. leprae and M. tuberculosis and that amino acid
homologies between ML and MT secreted proteins was found to be higher for the mature
polypeptide chains than for the corresponding signal peptides.
My study showed that differences between amino acid identities of ML and MT
signal sequences were 15.4 %. The same comparison for ML and MT mature proteins
was 8.13 %. These data are consistent with the concept that similar amino acids can
substitute for various signal sequence motifs (positively-charged, hydrophobic, etc.)
Similarly, mature proteins may allow fewer amino acid substitutions because of stringent
functional and structural requirements needed for structural or enzymatic activity.
Six out of 15 pairs of amino acid sequences showed the same percentage of
arginine at the N-region for M. leprae and M. tuberculosis proteins (Figure 1). The
arginine rich N-regions are most likely explained by the high G+C content found in
mycobacterial genomes and related preferred codon usage. It is interesting to note that
even though M. leprae has a much reduced overall genome G+C content (57.8%)
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compared to M. tuberculosis (65.6%), several secreted proteins identified in this study
had G+C% ratios in the order of 60% (Table 3). One possible explanation for the
difference between ML G+C content and MT G+C content might be that the ML genome
suffered a considerable loss of G+C in pseudogenes during reductive evolution. This
assumption agrees with the fact that the G+C content of functional ML genes is higher
than the G+C content of the overall ML genome (Table 3).
In summary, 204 M. tuberculosis known and predicted putatively secreted
proteins were used to search for homologous M. leprae proteins. The computer-based
analysis showed that 24 M. leprae proteins were predicted to be secreted. These data
suggest that Sec-dependent secretion is operative in M. leprae and is closely related to
commonly described Sec-dependent secretion in other Gram-positive microorganisms.
The cleavage-site motif for the signal peptidase was conserved in 20 of 24 ML proteins
studied and showed that M. leprae signal sequences were very similar to M. tuberculosis
signal sequences.
Fifteen M. leprae proteins showed 50% or greater homology with their
corresponding M. tuberculosis gene sequences and were selected for gene expression
studies (Chapter 3). Comparison alignments between M. tuberculosis and M. leprae
protein sequences showed that homologies between mature proteins are considerable
higher than homologies between signal sequences. Analysis of amino acid composition of
the N-region for both M. leprae and M. tuberculosis showed a high arginine content
which is consistent with the high G+C content of mycobacterial genes. In terms of amino
acid composition, my analysis showed that signal sequences from M. leprae were similar
to M. tuberculosis signal sequences.
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CHAPTER 3
M. LEPRAE GENE EXPRESSION AND SECRETION IN E. COLI AND M.
SMEGMATIS
3.1.Introduction
Secreted proteins represent a distinct group of proteins with respect to their structure,
function and contribution to virulence. They are of particular importance for vaccine
development because they are often immunogenic and have the potential to be recognized
early in infection. A requisite step in protein secretion is protein translocation across the
cytoplasmic membrane. This step is common to proteins that are released to the extracellular
space or remain associated with the cell wall. The Sec-dependent pathway translocates
precursor proteins containing N-terminal signal sequences across the cytoplasmic membrane
(Oliver and Beckwith, 1981).
Secretion systems in mycobacteria are important for the proper localization of
structural and metabolic components as well as virulence factors. However, little is known
about this aspect of mycobacterial physiology. In particular it is not known how proteins
escape from the cell wall of mycobacteria or how proteins lacking N-terminal signal
sequences are exported. The first evidence of a Sec-dependent pathway in mycobacteria was
the recognition of N-terminal signal peptides in the predicted amino acid sequences of known
M. tuberculosis and M. leprae secreted proteins (Harboe and Wiker, 1999; Gomez et al,
2000). The second indication that this pathway existed in M. tuberculosis and M. leprae
came from the identification of genes (Cole, et al, 1998) with sequence homology to known
proteins involved in Sec-dependent secretion in E. coli (Braunstein, et al, 2001).
The completion of the M. leprae genome sequence has provided investigators an
opportunity to use bioinformatics tools to predict gene function by comparing translated
protein sequences of M. leprae with those of other bacteria. Comparative genome analysis
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has provided new information about the Sec-dependent pathway in M. tuberculosis and M.
leprae including the presence of two SecA homologues (SecA1 and SecA2) (Braunstein et
al, 2001). Comparative genomics coupled with other bioinformatics tools, such as SignalP
and TMHMM can predict protein location in the bacterial cell and may aid approaches
designed to identify proteins with diagnostic or vaccine potential. As powerful as these tools
are they can only make predictions based on characteristics previously identified in proteins
with predetermined functions such as secretion. New unknown proteins may meet some but
not all of the critical characteristics sought and, therefore, may be excluded from analysis.
Alternatively, a protein may have unique characteristics not recognized by a particular
algorithm and, therefore, may not be secreted in vivo even thought it is predicted for
secretion in silico. Therefore, experimental validation is critical when using bioinformatics
tools for identifying proteins with potential for secretion.
Once various genes have been identified using bioinformatics tools it is important to
verify that the gene is expressed during intracellular growth. Identifying M. leprae genes
expressed during infection helps focus attention on bacterial factors necessary for survival
and growth within the human host, thereby increasing our understanding of the hostpathogen interaction. Gene expression has been studied in M. tuberculosis during infection
by reverse transcription-polymerase chain reaction (RT-PCR) and microarray analysis
(Mariani et al, 2000; Triccas and Gicquel, 2000). Virulent mycobacteria must adapt to
adverse conditions encountered during the infectious process. This means, at a mechanistic
level, that the amount of some bacterial proteins must be increased in response to the
changing environment and the amount of others must be lowered. The inability to culture M.
leprae represented a major obstacle to obtaining sufficient quantities of mRNA to perform
global gene expression analysis using conventional approaches. Just recently, new techniques
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to isolate highly viable bacteria from infected foot pad tissue have evolved that make
possible gene transcription analysis in M. leprae using gene specific RT-PCR based analysis
of mRNA (Truman and Krahenbuhl, 2001).
The most direct approach for studying secretion is to identify expressed proteins in
the extracellular space experimentally. For example, secretion can be studied in cultivable
bacteria by analyzing cell-free culture filtrates containing exported proteins. While this
approach has successfully identified major groups of secreted proteins from M. tuberculosis,
it cannot be applied to studying ML proteins since M.leprae cannot be grown in vitro.
Secreted proteins from M.leprae surely exist and are exported to the surrounding tissues
during infection; however, these proteins are lost when M.leprae is isolated from infected
tissues. Hibridization in situ with antibodies is another approach for studying secretion in
intracellular bacteria because it can be done in tissue. A new approach for studying secretion
is to take advantage of the properties of enzymes (e.g. alkaline phosphatase and β-lactamase)
that require translocation across the cell membrane to be detected. These genes can be fused
to unknown genes and act as a reporter in biological systems. For example the alkaline
phosphatase (phoA) gene lacks a promoter, ribosome binding site (RBS) and export leader
sequence. Fusion of phoA to an M. leprae gene supplying the missing upstream components
will result in secreted proteins which when expressed will have detectable PhoA activity.
Identification of reporter activity in bacterial colonies implies that the cloned fragment
supplies all three functions and, therefore, contains a portion of a gene encoding a secreted
protein. Alkaline phosphatase fusions have been used successfully to identify M. tuberculosis
(Lim et al, 1995) and M. avium exported proteins (Carroll et al, 2000) in a surrogate
organism, M. smegmatis. A similar approach using a β-lactamase gene and an upstream tac
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promoter was used to identify M. tuberculosis exported proteins in E. coli (Chubb et al,
1998).
This chapter describes the results from gene transcription studies of 15 ML proteins
predicted to be secreted using SignalP/TMHMM (Chapter 2). The mRNA was purified from
M. leprae grown in nude mice and gene transcription was monitored by RT-PCR. Each gene
was cloned into 2 separate reporter plasmids in an attempt to demonstrate proteins secretion
in either E. coli or M. smegmatis.
3.2.Materials and Methods
3.2.1.Bacterial Strains and Culture Conditions
M. leprae T-53 was isolated from a lesion of an untreated lepromatous leprosy patient
in Thailand in 1982 and maintained in serial-passage in the hind foot pads of athymic nude
mice (Hsd:Athymic Nude, Harlan, Indianapolis, IN) at the Laboratory Research Branch of
the National Hansen’s Disease Programs, Baton Rouge, LA.
E. coli XL-1 Blue supercompetent cells (Stratagene, La Jolla, CA) were cultured in
LB Lennox agar or broth (Life Technologies, Rockville, Maryland) supplemented with
antibiotics (ampicillin, 100 ug/ml or kanamycin, 50 ug/ml, Sigma-Aldrich Co., St Louis,
MO). M. smegmatis mc2 155 (ATCC, Rockville, Maryland) was cultured in Middlebrook
7H9 broth supplemented with Tween 80 (Difco Laboratories, Detroit, MI) for electroporation
and Middlebrook ADC (Becton, Dickinson and Company, Sparks, MD) or Luria Agar
Miller’s modified (Alpha Biosciences, Baltimore, MD) supplemented with kanamycin
50ug/ml. Both media contained 5-Bromo-4-Chloro-3-Indolyl Phosphate (BCIP) at 40 ug/ml
(Sigma-Aldrich Co.) for PhoA screening.

53

3.2.2.Plasmids
pQUANTagen (Qbiogene, Carlsbad, CA) is a fusion vector that contains a mutated
version of the E. coli alkaline phosphatase gene under the transcriptional control of the
synthetic tac promoter and the lacI repressor (Figure 3). The alkaline phosphatase gene is out
of frame in the vector and the reading frame is restored upon correct insertion of a cloned
DNA fragment. A BamHI-BglII site containing the sequence for the signal peptide for PhoA
in pQUANTagen that directs the fusion protein to the periplasm in pQUANTagen was
removed to study secretion and is referred to as pQUANTagen-sphoA. The plasmid also
carries the β-lactamase gene conferring ampicillin resistance for selective growth in E. coli.
pJEM11 was a gift from Denis Portnoi, Pasteur Institute, France. It has a phoA
reporter shuttle plasmid, origins of replication (ori) for E. coli and mycobacteria and a
multiple cloning site upstream of the phoA gene. The selectable marker is a kanamycin
resistance gene (Km). The truncated phoA gene is devoid of a promoter, start codon and
signal sequence. The expression and exportation of PhoA depends on translational fusion
with amino termini of other proteins encoding the necessary sequences.
3.2.3.Purification of M. leprae
Bacteria were harvested from foot pad tissue using a modification of a previously
described protocol by Truman and Krahenbuhl, 2001. Briefly, the hind feet were soaked in
ethanol for 1 min and the granulomatous foot pad tissue was removed, minced to a uniform
consistency with curved scissors and homogenized thoroughly for 1 min in a sterile tissue
grinder (Fisher/Pyrex, Houston, TX) containing 5 ml of cold Middlebrook 7H12 medium
(Difco/Becton Dickinson, Sparks, MD). Excess tissue was removed by centrifugation at 200
x g for 1 min at 4° C and the bacteria remaining in the supernatant fluid were pelleted at
10,000 x g for 10 min at 4° C. The pellet was resuspended in 10.5 ml Middlebrook 7H9 broth
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(Difco/Becton Dickinson) containing ampicillin (50ug/ml) and held for 3 hours at 37° C. An
aliquot was removed for acid-fast staining and counting (BBL7 TB Ziehl-Neelsen Kit,
Becton Dickinson Microbiology Systems). All M. leprae preparations were analyzed and
determined to be free of microbial contaminants by culturing the final M. leprae suspension
on a variety of media including: blood agar, Lowenstein-Jensen, thioglycolate broth and
trypticase soy broth (Becton Dickinson Microbiology Systems, Cockeysville, MD) for up to
2 weeks.
3.2.4.Purification of M. leprae and M. smegmatis RNA
RNA was purified from 2 x 1010 M. leprae T-53 or M. smegmatis mc2 155 using a
P
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P

P

modification of a previously described protocol by Hellyer et al, 1999. Aliquots containing 2
x 109 M. leprae or M. smegmatis were transferred to sterile RNAase-free 2 ml
P

P

microcentrifuge tubes (Sarstedt, Newton, NC) and pelleted by centrifugation at 10,000 x g
for 10 min at 4° C. Bacterial pellets were resuspended in 80 µl of DEPC-H2O (SigmaB
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Aldrich Chemical Co. St. Louis, MO). TRIzol® Reagent (Invitrogen, Carlsbad, CA) (920 µl)
was added to each tube to maintain the RNA integrity while disrupting cells and dissolving
cell organelles; the contents were transferred to a FastRNA® Blue tube (FastRNATMKit-Blue,
P
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P
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Qbiogene, Carlsbad, CA). Bacterial cells were lysed and total RNA was extracted by
homogenization in a FastPrep® FP120 Instrument (Qbiogene) for 45 sec at a speed setting of
P

P

6.5. Tubes were cooled for 5 min, then this procedure was repeated and the tubes were held
on ice for 5 min. A 200 µl aliquot of chloroform/isoamyl alcohol (CIA) (24:1) (Sigma
Aldrich) was added to each tube and tubes were mixed by vortex for 1 min. The glass matrix
was pelleted by centrifugation at 700 x g for 5 min and the top, aqueous layer was transferred
to a new 1.5 ml microcentrifuge tube. Cleanascite HC (CPG Biotech, Lincoln Park, NJ) (100
µl) was added to the each tube and the tubes were mixed on a rocking platform for 10 min.
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The Cleanascite was pelleted by centrifugation at 10,000 x g for 1 min and the supernatant
fluids were added to fresh 1.5 ml tubes containing 500 µl CIA and vortex mixed for 10 sec.
The phases were separated by centrifugation at 10,000 x g for 2 min and the top aqueous
phase was transferred to a 1.5 ml microcentrifuge tube. GlycoBlue™ co-precipitant,
(Ambion, Inc., Austin, TX) (1 µl), 1/10 volume of 5M NH4OAc and an equal volume of cold
B

B

isopropanol were added. The tubes were mixed and the RNA was precipitated at –80° C
overnight. RNA was collected by centrifugation at 10,000 x g for 10 min at 4° C and the
pellets were washed in 500 µl of salt/ethanol wash solution (FastRNATM Kit-Blue), air-dried
P
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for 10 min and dissolved in 50 µl of DEPC-treated water (FastRNATM Kit-Blue). RNA was
P
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pooled and DNA was removed from these preparations using the DNA-free™ kit (Ambion,
Austin, TX). Briefly, 50 µl aliquots of RNA were treated with 2 units of DNase (Ambion) at
37ºC for 1 hr, the reaction was stopped with Dnase inactivation reagent (Ambion) and
centrifuged for 1 minute at 10,000 rpm to pellet the reagent. Purified RNA was transferred to
a new 1.5 ml tube and stored at -80°C.
3.2.5.Reverse Transcription of M. leprae RNA
Total RNA was converted to cDNA with random hexamer primers and MMLV
reverse transcriptase (Advantage RT-for-PCR Kit, BD Biosciences, Clontech, Palo Alto,
CA), according to manufacturer’s recommendations. Briefly, primers and RNA were
incubated at 70ºC for 2 minutes followed by 5 minutes at 4ºC. The master mix containing the
reverse transcriptase was added and the reaction was incubated at 44ºC for 1 hr, heated at
94ºC for 5 minutes to stop cDNA synthesis and to destroy any DNase activity; and
resuspended in a final volume of 100 µl. A control for monitoring genomic DNA
contamination in the RNA extract consisted of RNA incubated with the reverse transcription
reagents as described above excluding the reverse transcriptase (RT-). cDNA was also made
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from BALB/c mouse spleen total RNA (BD Biosciences, Clontech) and human peripheral
blood mononuclear cell RNA. These cDNAs were used as specificity controls for M. leprae
genes by PCR assays.
3.2.6.PCR Amplification
M. leprae T-53 (107 AFB) were disrupted by 3 cycles of freezing and thawing at
-70ºC for 15 minutes and 95ºC for 5 minutes. DNA in the disrupted bacterial suspension was
used as template to amplify 15 ML predicted secreted genes that were found to have > 50%
amino acid identity with M. tuberculosis proteins (Table 2). PCR primers and amplification
protocols were designed for M. leprae genes by acquiring gene sequences from the M. leprae
genome database at the Sanger Centre (www.sanger.ac.uk) and using OmigaTM 2.0 Primer
Design software (Oxford Molecular Ltd, Madison, WI). PCR assays were initially
characterized for specificity using 1 ng M. leprae T-53 DNA and mouse spleen cDNA.
PCR fragments were separated by gel electrophoresis on 2% NuSieve GTG-SeaKem GTG
(1:1) agarose gels (BioWhitaker, Rockland, ME) in TAE buffer (4 M Tris-acetate, pH 8.0, 1
mM EDTA). Ethidium bromide-stained gels were visualized by UV transillumination and
photographed using a GelDoc®2000 Instrument (Bio-Rad Systems, Hercules, CA). The
amplicons were purified using QIAquick PCR columns (QIAGEN, Valencia, CA) and DNA
sequences of PCR fragments were obtained by automated DNA sequencing on an Applied
Biosystems sequencer (GeneLab, SVM, LSU, Baton Rouge, LA). Transcription analysis was
performed by PCR (40 cycles) using cDNA from M. leprae as template and gene specific
primers for amplification. PCR conditions were denaturation at 94º C for 30 seconds,
annealing for 1 minute at Tº (temperature determined by Omiga 2.0 Primer Design software)
and primer extension at 72º C for 2 minutes.
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3.2.7.Cloning ML Genes into pQUANTagen
M. leprae T-53 DNA was used as template for initial gene specific PCR
amplification. PCR conditions were 40 cycles of denaturation at 94º C for 30 seconds,
annealing for 1 minute temperature determined by Omiga, 1st PCR, Table 4 and primer
P
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extension at 72º C for 2 minutes. The PCR products were separated and purified as described
above. A 2nd PCR, used to amplify the gene of interest was performed on the purified
P

P

amplicon from the 1st PCR as template using primers containing restriction enzyme sites for
P
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cloning into pQUANTagen (Figure 3). PCR conditions were the same as those used for the
1st PCR with the annealing temperature set at 60º C for all of the genes amplified in the 2nd
P
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P
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PCR. Fifteen M. leprae genes encoding predicted secreted proteins were amplified from the
start codon (ATG or GTG) to a few bases before the stop codon for cloning into
pQUANTagen. Amplification primers included two different restriction sites for
unidirectional cloning except when using BamHI with BglII (Table 4). PCR products were
purified and digested with appropriate restriction enzymes (New England Biolabs, Beverly,
MA) for cloning (Table 4) and separated by gel electrophoresis on 0.8% NuSieve GTGSeaKem GTG (1:1) agarose gels. Restricted pQUANTagen vector and PCR fragments were
purified from agarose gels using QIA quick Gel Extraction kit, Qiagen. Ligation was
performed at a molar ratio of 2:1 (insert:vector) with 1unit of T4 ligase (Invitrogen, Carlsbad,
CA) at 14ºC overnight. Recombinant plasmid DNA was introduced into E. coli XL-1 blue
supercompetent cells by transformation (Stratagene, La Jolla, CA). Briefly, 100ul of cells
were placed in prechilled 15 ml tubes for each transformation. β-mercaptoethanol
(Stratagene) 1.7ul was added and cells were held on ice for 10 minutes. The ligation mixture
(10ul) was added to each tube and then held on ice for 30 minutes. The tubes were incubated
at 42ºC for 45 seconds (heat pulse) and then held on ice for 2 minutes. SOC medium
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(Qbiogene, Carlsbad, CA) (0.9 ml) was added to each tube followed by incubation at 37ºC
for 1 hour with shaking at 225 rpm. The transformation mixture was plated on Luria agar,
supplemented with ampicillin and BCIP. ML gene-pQUANTagen recombinant plasmids
were screened for phoA expression in E. coli XL-1 blue cells. Blue colonies were recovered
at day 2 and restreaked to obtain single-colony isolates. Transformants were screened for
carriage of pQUANTagen recombinant derivatives with ML gene insert by PCR of frozen
and thawed (3X) bacterial lysates. Primers for PCR detection of ML insert (Figure 2) were
designed using OmigaTM 2.0. DNA sequences of PCR fragments were obtained by
automated DNA sequencing on an Applied Biosystems sequencer (GeneLab, SVM, LSU,
Baton Rouge, LA).

Figure 3: Map of pQUANTagen.The PhoA signal sequence (sphoA) corresponding to
BamHI (nucleotide position 1570)-BglII (nucleotide position 1711) was removed from the
original vector before cloning to create pQUANTagen (- sphoA). In some cases the plasmid
was cut with BsrGI (nucleotide position 1585) when ML genes that showed BamHI sites
within the gene. The plasmid was cut with KpnI (nucleotide position 1735) or SalI
(nucleotide position 1726) when ML genes showed BglII sites in the restriction map of the
gene (Table 4).The tac promoter is located upstream of the phoA gene. Primers for DNA
sequencing were located at nucleotide position 1525 (forward primer: 5’CCAAGCTTACTCCCCATCCCC-3’) and nucleotide position 1824 (reverse primer: 5’CAGTCTGATCACCCGTTAAAC-3’).
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3.2.8.Cloning ML Genes into pJEM11
Fifteen M. leprae gene sequences were screened for putative promoter areas using the
Gene and Functional Signal Finding Program (www.softberry.com) and 10 genes were
HTU

UTH

selected for cloning into pJEM11 based on the presence of potential upstream elements for
promoter activity. pJEM11 is a phoA reporter shuttle plasmid which replicates in E. coli and
M. smegmatis and expresses kanamycin resistance in both genetic backgrounds (Figure 4).
Primers containing BamHI restriction sites were designed for cloning into pJEM11 (3rd PCR,
P
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Table 4). PCR conditions were the same as used for the 1st PCR (Table 4), but the annealing
P
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temperature was 60º C for all genes amplified. PCR products were purified and digested with
BamHI. pJEM11 was digested with BamHI and dephosphorylated with calf-intestine alkaline
phosphatase (CIP). PCR products and pJEM11 were purified from agarose gels as described
above. Recombinant plasmids were propagated in E.coli XL-1 blue. Plasmid DNA from
colonies recovered on LB plus kanamycin plates was isolated using a QIAprep spin miniprep
kit (Qiagen). Purified plasmid DNA was introduced into electrocompetent M. smegmatis mc2
P

155 cells by electroporation using a Bio-Rad Gene Pulser (Hercules, CA) following a
P

previously described protocol by Cirillo et al, 1993. Briefly, a culture (400ml) of M.
smegmatis mc2155 was grown at 37ºC for 2 days with constant shaking until reaching mid
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log growth (approximately 48 hrs.). The culture was held on ice for 1 hour and then
centrifuged for 10 minutes at 5,000 x g at 4 ºC. The pellet was washed with cold 10%
glycerol three times and the final bacterial pellet was resuspended in 1 ml of 10% glycerol.
One-hundred ul of this cell suspension and 50 ng of DNA were placed in 1.5 ml
polypropylene tubes for each electroporation. The Gene Pulser apparatus was set at 2.5 kV,
25uF and 900 Ω. After delivering the pulse, the cell/DNA mixture was transferred to a
culture tube containing 1 ml of 7H9 plus ADC and incubated at 37ºC with constant shaking
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for 2 hours. Recombinant M. smegmatis colonies were screened for phoA expression on
Luria agar containing kanamycin and BCIP. Blue colonies were recovered on days 7-14 and
restreaked to obtain single-colony isolates and confirm phoA reporter activity. Transformants
were screened for carriage of pJEM11 recombinant derivatives by PCR as described above
with pQUANTagen recombinants. Primers in the multiple cloning site and E. coli phoA gene
sequence were designed with OmigaTM 2.0. DNA sequence of ML genes were obtained by
automated DNA sequencing on an Applied Biosystems sequencer (GeneLab, SVM, LSU,
Baton Rouge, LA)

Figure 4: Map of pJEM11. pJEM11, a phoA reporter shuttle plasmid, has origins of
replication (ori) for E. coli and mycobacteria and a multiple cloning site (MCS) upstream the
phoA gene, represented by BamHI site. The selectable marker is the kanamycin resistance
gene (Km). The truncated phoA gene is devoid of the promoter, start codon and signal
sequence; the expression and exportation of PhoA depends on translational fusion with
amino termini of other proteins encoding these sequences. The transcriptional terminator
avoids transcription by read-through from plasmid sequences. Primers for DNA sequencing
were located at the multiple cloning site (forward primer: 5’-CTAGTACTGGGCCCGCGG
AT-3’) and E. coli phoA gene (reverse primer: 5’-CCCCATCCCATCGCCAAT-3’
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Table 4: Primers used for PCR cloning ML genes into plasmid vectors
Gene name

1st PCR from ML lysates
Primers 5’→ 3’
GGTCGCAATTACCTCACG
GTCAGGTGACAGGTTCTTCG
CAGGAATTTTAGACAGGCATCG
AGCCCCTAAATACTGCTGAAGG
CTTGCATCGAATCATCG
CCTCCCTAGCGAATGG
GATACGAAAGACCAGGAACAAGG
CGACACGGAAACGTCAGC
TTCAACCCTGACCGCACC
GAAAAACTGCGCGATAACTTCC
CTCTGTTGCAGGATGAACG
ACCCGACGAATTCATCG
TAAACGAGGCTGAATATCAACG
CGAATCAAGACTCGATGATCC
TGCAGTTTGTGACTTGCGTTTCC
TATTCGATGTAGCGGACCACATACG
TCGCTGCTGGAATTCGAGG
CCCGATATACGGCCATTTGC
CGTAAGACAACCGCTGAGG
GGGGTACAGCCATCAAGG
AAGTATATCATCCGGCTTATGAAGG
GTTGCAGGATGCCTATTTGG
AACACACGAGTTAGCCTCCGTATCG
GGCAAGGAAGCCCTCGACG
P

ML0091

AT
61

Ampl
884

ML0097

60

1301

ML0098

60

965

ML0620

60

516

ML0715

62

1054

ML0885

58

1392

ML1811

61

759

ML1812

65

1572

ML1923

64

1219

ML2028

61

1383

ML2274

60

340

ML2331

60

747

1 nd

P

P

Ampl
692

2 PCR
R.E.
BamHI-BglII
P

P

P

2 rd

3 PCR
Ampl*
603
P

P

P

P

973

BamHI-BglII

813

919

BamHI-BglII

640

418

BamHI-BglII

514

901

BamHI-BglII

670

1073

BamHI-KpnI

865

735

BsrGI-BglII

---

1349

BsrGI-SalI

950

1200

BsrGI-KpnI

---

983

BamHI-BglII

750

340

BamHI-BglII

---

688

BamHI-BglII

--(Table continued)
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ML2380

60

512

ML2569

60

1502

ML2591

65

1555

GTTCCTGCTGGCTCGTAAGC
TGGTACTGGTTGCAAACCTCG
ACGAGTCCGCCAGCGTTTTTACC
CCTTCTCTAGCCGGTCCAAGACTGC
GCTGGAACTCCCCAATCG
TACTCAATTCCGACTACCTCCTGC

455

BamHI-BglII

512

969

BamHI-BglII

850

1417

BsrGI-BglII

---

AT: Annealing temperature
* Length of amplicon of first, second and third PCR in base pairs (bp)
R.E: Restriction enzymes used for cloning into pQUANTagen.
---- Gene was not cloned in pJEM11 because there was no putative promoter region identified.
1 A second PCR was performed on the purified amplicons from the first PCR using primers containing appropriate restriction sites for
cloning into pQUANTagen.
2 A third PCR was performed on the purified amplicons from the first PCR using primers containing BamHI sites at the 5’ and 3’ ends.
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3.2.9.Detection of mRNA for ML Genes Cloned into M. smegmatis
Primers specific for each ML gene that was successfully cloned in pJEM11(ML0091,
ML0097, ML0098, ML0715, ML2028, ML2380 and ML2569) were designed to amplify a
fragment from each M. smegmatis transformant cDNA. mRNA expression analysis was
performed using cDNA from M. smegmatis transformants and the same conditions for first
PCR assay as described above.
Table 5: Primers and amplicon sizes for 7 ML genes cloned in M. smegmatis for mRNA
transcript analysis.
Gene name
ML0091 (erp)

Amplicon (bp)
300

Primers* 5’→ 3’
ACCCGCGGCCAAACACTATG
CAGGTGCCACCCAGGTTCAG
CCGGTGGAGTACCTTCAGGT
ML0097
400
GTGGTAGATCGCCAGCGTC
(fbpA)
GCAATGGGCCGGGATATTCC
ML0098
350
CGGTCGGGGTGGAAAGCC
(fbpC)
CGCCAGGCTCTCCTGTGG
ML0715
700
GCCCGCACCTTCGGCATAA
(lpqC)
GACCGCAAGCGCGTTCTC
ML2028
300
CTTGTAGGTCGTGCAACCTGCC
(fbpB)
GGATTTTCCGATCCCCCGC
ML2380
250
CCAATGCGTGGCCATCTGCT
GCCACGATGTTGCACAGGCT
ML2569
430
TTGTGACCACGGTCCAGCG
* Specific primers designed to amplify a portion of each gene. Annealing temperatures were
60ºC except for ML2028 which was 65ºC.
3.2.10.ML Protein Expression in M. smegmatis and E. coli
Late log cultures of recombinant E. coli and M. smegmatis were harvested by
centrifugation at 6000 x g (4ºC) for 15 minutes. Culture supernatants were precipitated with
iced-cold 100% ethanol (Sigma), the precipitate collected by centrifugation at 11,000 x g (4º
C) for 30 minutes and the pellet was dried and resuspended in 100ul PBS. Bacterial pellets
were washed 3 times with phosphate buffered saline, pH 7.4 (PBS) and resuspended in 0.5
ml of PBS. M. smegmatis samples were sonicated (3 cycles of 10 minutes at 50% power)
using a microtip sonicator with an Ultrasonic Homogenizer 4710 (Cole-Parmer Instrument
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Co., Chicago, IL). The bacterial sonicates were span at 11,000 x g (4º C ) for 10 minutes and
the supernatants were transferred to clean tubes. Total proteins of culture filtrates and
bacterial sonicates were measured by BCA Protein Assay (Pierce, Rockford, IL) using BSA
as a standard.
Concentrated culture supernatants and bacterial sonicates (200 µg) were analyzed by
immunobloting after separation of proteins on 10% polyacrylamide gels containing sodium
dodecylsulfate (SDS-PAGE). Sonicates and culture filtrates mixed (1:1) with sample buffer
(62.5mM Tris-HCl, 10% glycerol, 2% SDS, 0.05% β-mercaptoethanol, 0.05% bromophenol
blue) and loaded onto gels. SDS-PAGE gels were run for 2 hours at 25 mA and 2 hour at 50
mA in a Protean II xi cell (Bio-Rad, Hercules, CA) and blotted on Immobilon-P transfer
membrane (Millipore, Bedford, MA) using a trans-blot cell (Bio-Rad) overnight at 12 V in
Tris-glycine buffer containing 30% methanol (Sigma). The membrane was blocked with 3%
BSA (Sigma) in PBS at room temperature for 45 minutes followed by incubation at room
temperature for 2 hours with mouse anti-E. coli alkaline phosphatase monoclonal antibody
(Chemicon International, Inc., Temecula, CA), diluted 1:2500 in 1% BSA in PBS. The
membrane was washed 3 times with PBS containing 0.05% Tween 20 (Sigma), incubated at
room temperature for 1 hour with horseradish peroxidase (HRP) conjugated goat anti-mouse
immunoglobulins (Dako Corp., Carpenteria, CA) diluted 1:2000 in 1% BSA in PBS. The
membrane was washed again as stated above and placed in HRP color development reagent
(30 mg of 4-chloro-1-naphthol) (Bio-Rad) in 10 ml of methanol, 300 µl of 3% hydrogen
peroxide (Medic, Jacksonville, FL) and 50 ml of Tris-buffered saline, pH 7.5 at room
temperature for 10 minutes.
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3.3.Results
3.3.1.Gene Expression of 15 Putatively Secreted Proteins in M. leprae during Infection
in the Nude Mouse
Fifteen ML predicted secreted proteins that showed 50% amino acid homology with
M. tuberculosis (Table 2) were selected for studying gene transcriptionion in M. leprae
during intracellular growth in the nude mouse by RT-PCR. Amplicons produced by RT-PCR
showed predicted DNA fragment sizes for each of the 15 genes tested. An example of one
RT-PCR gene transcript analysis is shown in Figure 5.Both the cDNA (lane 2) and genomic
DNA (lane 5) produced amplicons of the appropriate size (450 bp) for the ML0097 (fbpA)
gene. DNA sequencing of the amplicon confirmed the existence of fbpA mRNA in M. leprae
during infection of nude mice. Mouse cDNA and RT(-) ML samples were run as negative
controls for each gene (Figure 4). These data confirm that all 15 M. leprae genes identified as
putatively secreted proteins are transcribed during infection and, therefore, may be critical for
maintenance of intracellular survival during infection.
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2

3

4

5

Figure 5: Agarose gel electrophoretic analysis of PCR products of ML0097 (fbpA) from
ML genomic and cDNA derived from ML-infected nude mice. Lane 1 1kb ladder, lane 2
M. leprae, strain T53 cDNA, lane 3 normal mouse cDNA, lane 4 RT (-) and lane 5 M. leprae
genomic DNA.
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3.3.2.Cloning ML Genes into pQUANTagen
15 ML genes were amplified by PCR (Table 4) for cloning into pQuant (- sphoA), a
vector that contains the alkaline phosphatase gene under the transcriptional control of the
synthetic tac promoter. The signal peptide for phoA that directs the fusion protein through the
membrane to the periplasm of E. coli was removed to study secretion of the 15 ML
putatively secreted proteins (Figure 3) in E. coli. Ligation mixtures for each gene were
transformed into E. coli XL-1 blue supercompetent cells and produced between 100-200
Ampr transformant colonies. All ML gene transformants produced blue and white colonies
on agar plates supplemented with the substrate for the alkaline phosphatase with the
percentage of blue colonies per transformant ranging from 10% to 70%.
3.3.3.PCR Amplification and Sequence Analysis of M. leprae Inserts in pQUANTagen
For each ML gene E. coli transformation ten colonies were pooled and used to
inoculate LB plus Amp media. Plasmid DNA from these cultures were purified, amplified
by PCR with primers designed for sequencing in pQUANTagen and were analyzed on
agarose gels. PCR products that matched gene insert size (Table 6, Figure 6) were sequenced
starting 30-40 bases upstream of the ML gene start codon to authenticate gene orientation
and reading frame. Blue colonies recovered from E. coli transformants ML0091, ML0097,
ML0620, ML1811 and ML1812, and white colonies from one E. coli transformant ML2380
confirmed proper gene insert and alignment for expression (Table 6). While proper gene
insert and alignment were found for ML0091, ML0097, ML1811 and ML1812 sequences
were incomplete finishing before the stop codon for each gene. DNA sequencing from only
two gene inserts ML0620 and ML2380 verified the presence of the complete gene inserts
(Table 6). DNA from E. coli transformants ML0098, ML0715, ML0885, ML1923, ML2028,
ML2274, ML2331, ML2569 and ML2591 each produced a PCR fragment of about 300bp
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indicating the absence of a ML gene insert (Table 6 and Figure 6). An example of two E. coli
transformants containing ML genes ML0091 and ML0097 is shown in Figure 6. E. coli
transformants produced amplicons of the appropriate size for the ML0091 (992 bp ) and
ML0097 (1273 bp) genes and where no insert was detected showed a band at 300 bp.
Table 6: ML PhoA gene fusions in E. coli
Gene name

Reporter in E. coli
blue

ML gene insert*
(bp)
992

Sequence length**
(bp)
620

ML0091 (erp)
ML0097 (fbpA)

blue

1273

510

ML0098 (fbpC)

1

---

300

---

ML0620 (mtb12)

blue

718

Complete gene

ML0715 (lpqC)

---

300

---

ML0885

---

300

---

ML1811

blue

1035

620

ML1812

blue

1649

470

ML1923 (lpqF)

---

300

---

ML2028 (fbpB)

---

300

---

ML2274

---

300

---

ML2331

---

300

---

ML2380

2

755

Complete gene

ML2569

---

300

---

ML2591(mce1C)

---

300

---

white

1 Low percentage of blue colonies all testing negative for gene inserts, all white colonies
tested showed no gene insert.
2 Low percentage of blue colonies all tested negative for gene insert, some white colonies
tested positive for gene insert.
* ML gene inserts amplified by PCR with pQUANTagen primers have amplicon sizes of 2nd
PCR (Table 4) plus multiple cloning site from pQUANTagen (300bp). ML genes with no
insert identified by PCR showed amplicon size of 300bp, the same as the multiple cloning
site of pQUANTagen.
** DNA sequences of cloned genes from PCR products yielding predicted amplicon sizes
were determined beginning 30-40 bases upstream of ML gene start codon and finishing after
the ML gene stop codon (ML0620 and ML2380) or before the ML gene stop codon
(ML0091, ML0097, ML1811 and ML1812).
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Figure 6: Agarose gel electrophoretic analysis of PCR products from E. coli
transformants containing ML genes. Lane 1, ML0091 (992 bp), lanes 2 and 3,
transformants without insert, lanes 4, 1kb ladder , lane 5 pQUANTagen plasmid, lane 6
ML0097 (1273 bp).
3.3.4.Cloning ML Putatively Secreted Protein Genes into pJEM11
Because pJEM11 contains a truncated phoA reporter gene without a promoter, start
codon and signal sequence (Figure 4), 10 ML genes (ML0091, ML0097, ML0098, ML0620,
ML0715, ML0885, ML1812, ML2028, ML2380 and ML2569) were selected for analysis in
pJEM11 based on their putative possession of the required genetic elements. These 10 ML
genes (Table 4) were amplified by PCR and cloned into pJEM11. Each ligation mixture was
first transformed into E. coli XL-1 Blue supercompetent cells from which 50-100 Kanr
transformant colonies were recovered for each ML gene. For each cloned gene plasmid
DNA was purified from a culture grown from a pool of colonies and introduced into mc2155
by electroporation. Twenty to forty Kanr M. smegmatis transformants colonies were
recovered from Luria agar plates containing BCIP. Blue colonies, representing M. smegmatis
transformants capable of exporting alkaline phosphatase, were identified from transformants
ML0715 and ML2569 (Table 7 and Figure 7). White colonies, representing M. smegmatis
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transformants without a gene insert or with a gene insert lacking all or some of the required
genetic elements for transcription, translation or secretion, were identified from
transformants ML0091, ML0097, ML0098, ML0620, ML0885, ML1812, ML2028 and
ML2380 (Table 7).
3.3.5.PCR Amplification and Sequence Analysis of M. leprae Inserts in pJEM11
DNA from each of ten colonies from M. smegmatis transformants for each ML gene
was amplified by PCR with primers for sequencing in pJEM11 (Figure 4). PCR products
from all clones except (ML0620, ML0885 and ML1812) matched predicted gene insert sizes
(Table 7) and were sequenced starting 30-40 bases upstream of ML gene start codon and
finishing from 400 to 800 bases before the ML gene stop codon. ML genes with correct
orientation and reading frame were confirmed for the first 380 bp of M. smegmatis
transformant ML0715 and the first 430 bp of M. smegmatis transformant ML2569. Also, ML
gene inserts with correct orientation and reading frame were confirmed in 5 M. smegmatis
transformant (white colonies) by sequencing the first 395bp (ML 0091), 430 bp (ML0097),
180 bp (ML0098), 210 bp (ML2028) and 200 bp (ML2380) (Table 7). Plasmid DNA from
three M. smegmatis transformants yielding white colonies (ML0620, ML0885 and ML1812)
produced PCR fragments of 250bp indicating the absence of a gene insert (Table 7). The
analysis of promoter areas showed that 4 of 10 ML genes (Table 7) did not have identifiable
RBS, -10 or -35 regions in the 200 bp segment analyzed suggesting that these 4 genes may be
located within discrete operons.
Table 7: ML PhoA gene fusions in M. smegmatis.
Gene name

Promoter*

ML0091 (erp)

ML gene
insert** (bp)
853

RBS

Reporter in
M. smegmatis
white

Sequence
length^(bp)
395

ML0097 (fbpA)

1063

RBS

white

430
(Table continued)

70

ML0098 (fbpC)

890

RBS, -10

white

180

ML0620 (mtb12)

250

NI2

white

---1

ML0715 (lpqC)

920

-10, -35

blue

380

ML0885

250

RBS, -10, -35

white

---

ML1812

250

NI

white

---

ML2028 (fbpB)

1000

-10, -35

white

210

ML2380

762

NI

white

200

ML2569

1100

NI

blue

430

1 No gene insert identified by PCR.
* RBS were identified by The Sanger Centre annotation of ML genome and –10 and –35
regions were identified using the Gene and Functional Signal Finding Program, SoftBerry
(www.softberry.com).
** ML gene inserts amplified by PCR with pJEM11 primers have the size of amplicon sizes
of 3rd PCR (Table 4) plus multiple cloning site from pJEM11 (250bp). ML genes with no
insert identified by PCR showed amplicon sizes of 250bp, the same as the multiple cloning
site of pJEM11.
^DNA sequences of cloned genes from PCR products yielding predicted amplicon sizes were
determined beginning 30-40 bases upstream of ML gene start codon and finishing before the
ML gene stop codon.
2 NI, nothing identified resembling a promoter or ribosome binding site
Agarose gel electrophoresis analysis of PCR fragment sizes for two pJEM11 cloned genes is
shown in Figure 8. ML DNA from M. smegmatis transformants produced amplicons of the
appropriate size for the ML0091 (853 bp) and ML0715 (920 bp) genes. Clones containing
plasmid with no insert gave PCR fragments equivalent to 250 bp (Table 7).

pJEM11

ML2569

Figure 7: Colonies of M.smegmatis following pJEM11 transformation by
electroporation. Transformants were plated in Luria agar with Kan and BCIP. Inset of plate
ML2569 shows close-up of 2 blue colonies and a white colony.
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Figure 8: Agarose gel electrophoretic analysis of PCR products from M. smegmatis
transformed with pJEM11-ML gene fusions.
Lane 1 and 2, transformants ML0091, lanes 3 and 12 1kb ladder , lanes 4 and 5 transformants
ML0715, lanes 6 and 7 transformants with no insert, lanes 8, 9, 10 and 11 pJEM11 plasmid.
3.3.6.Transcription of ML Genes Cloned into M. smegmatis
Because 5 M. smegmatis transformants contained a portion of a cloned ML gene but
produced white colonies on culture, RT-PCR was employed to determine whether genespecific mRNA was present in growing M. smegmatis cells. cDNA from total RNA was
prepared using specific primers for each ML gene (ML0091, ML0097, ML0098, ML0715,
ML2028, ML2380 and ML2569) cloned into M. smegmatis. mRNA from ML0715 was
identified by PCR using a forward primer made from ML0715 gene sequence and a reverse
primer made from E. coli phoA gene sequence (Table 5). Authentic ML gene sequences
were confirmed by sequencing the PCR products.
An example of detecting mRNA from an M. smegmatis transformant containing
ML0097 is shown in Figure 9. DNA and cDNA from M. smegmatis transformant ML0097
produced a 450 bp amplicon confirming transcription in M. smegmatis (Table 5). Negative
controls RT (-) and pJEM11 plasmid DNA produced no discernible PCR product on gels.
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Figure 9: Agarose gel electrophoretic analysis of RT-PCR products derived from cDNA
from M. smegmatis transformants. Lane 1, RT (-), lane 2 pJEM11, lane 3 ML0097 DNA
amplified with specific primers. Lanes 4 and 5 M. smegmatis transformant ML0097 cDNA
amplified with ML 0097 gene specific primers, respectively. Lane 6 contained 100 bp ladder.
3.3.7.Immunoblot Detection of PhoA Fusion Proteins in M. smegmatis and E. coli
Lysates prepared from recombinant E. coli clones (ML0091, ML0097, ML0620,
ML1811 and ML1812) producing blue colonies on BCIP containing media were tested by
immunoblotting for expression of ML-PhoA fusion proteins. Bacterial sonicates prepared
from recombinant M. smegmatis clones (ML0715 and ML2569) producing blue colonies and
recombinant M. smegmatis clones (ML0091, ML0097, ML0098, ML2028 and ML2380)
producing white colonies on BCIP-containing media were also tested by immunoblotting for
expression of ML-PhoA fusion proteins. A recombinant E. coli strain producing high levels
of native PhoA was used as a positive control.
Immunoblots of E. coli transformants ML0620, ML0097 and ML0091 identified a
band at approximately 50 kDa corresponding in size with native E. coli alkaline phosphatase
(Fig 10). ML0620-phoA and ML0097-phoA fusions showed a second band at approximately
63 kDa and 84kDa, respectively (Fig 10). These protein bands corresponded to their
respective predicted molecular weights for each ML-phoA fusion protein. ML0091-phoA
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fusion showed two other bands at approximately 55 kDa and 90 kDa, neither of which
corresponded to the predicted molecular weight for the authentic ML0091-phoA fusion of 73
kDa. Extracts from E. coli transformant ML0098, in which a cloned insert could not be
identified by PCR (Table 6), showed no bands detectable by immunoblotting (Fig 10).
Culture filtrates containing 200 ug of protein from cultures of all recombinant clones were
tested by immunoblotting and showed no detectable bands under identical conditions used
above (data not shown).
All attempts to identify fusion proteins in extracts from recombinant M. smegmatis
clones were unsuccessful (data not shown). Both bacterial sonicates and culture filtrates
showed negative profiles in immunoblots under identical conditions used above.

1
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5
6
Figure 10: Western blot of M. smegmatis and E. coli ML transformants.
Lysates from M. smegmatis and E. coli transformants were electrophoretically separated on
10% SDS-PAGE, transferred to Immobilon-P membrane and reacted with 1:2,500 dilution of
monoclonal anti-phoA Lane 1 MW marker, lane 2 is native E. coli phoA, lanes 3, 4, 5 and 6
are E. coli transformants ML0620, ML0098, ML0097 and ML0091 respectively.
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3.4.Discussion
Characterization of exported proteins in M. leprae is important because it will provide
a better understanding of the signals that direct proteins to the cell membrane, to the cell wall
and to the bacteria’s surrounding immediate exterior as soluble secreted proteins. Some of
the exported proteins are involved in the building of the mycobacterial cell wall, such as the
antigen 85 complex (fbpA, B and C), but the majority of exported proteins have not been
functionally characterized. A comprehensive study of exported proteins in mycobacteria is
needed to identify those proteins involved in cell envelope biogenesis, immunogenicity and
virulence. In efforts to identify ML secreted proteins this work has explored the utility of
bioinformatic tools for predicting secretion in M. leprae and has explored the usefulness of
secretion vectors for the identification and validation of secretion of proteins in E. coli and
M. smegmatis.
Fifteen ML proteins that showed greater than 50% amino acid sequence homology
with a known or predicted M. tuberculosis secreted protein were selected for studying gene
expression in M. leprae during intracellular growth in the nude mouse. All 15 putatively
secreted protein genes were transcribed in M. leprae during infection suggesting that all 15
M. leprae genes are likely critical for maintenance of intracellular survival during infection.
Seven of the M. leprae proteins identified in my study have been shown previously to be
associated with virulence in M. tuberculosis (fbpA, B and C, Rv2190c similar to ML0885,
Rv1477 similar toML1812, Rv1478 similar to ML1811 and mce1C), correlates with the
observation of Finlay and Falkow, 1997, and Miller and Cossart, 1999, who showed that the
majority of virulence factors in bacteria are extracytoplasmic proteins.
Williams et al, 2003, studied gene expression of over 200 ML genes during infection
in nude mice. The study included genes involved in Sec-dependent secretion, DNA
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replication, transcription, virulence factors, iron acquisition and numerous metabolic
pathways. While only a small percentage of the 1600 potential genes of M. leprae were
studied greater than 90 percent of the genes analyzed were transcribed. These data supported
earlier speculation that since M. leprae has undergone a rather severe loss of genes due to a
reductive evolutionary process, the remaining genes of M. leprae may define a minimal set of
genes necessary for growth and survival of an intracellular mycobacterial pathogen.
Accordingly, the relatively low number of potentially secreted proteins identified in my
dissertation studies is in keeping with this interpretation. It is interesting to note that only 271
genes were necessary for survival of the free-living nonpathogen, B. subtilis (Ehrlich et al,
2003). Comparisons between minimal gene sets of free-living and pathogenic bacteria may
help define genetic elements important in intracellular survival and help elucidate pathogenic
mechanisms of mycobacteria and other intracellular pathogens.
PhoA fusion studies using a modified pQUANTagen without the phoA signal
sequence, showed that 5 ML proteins (ML0091, fbpA, ML0620, ML1811 and ML1812)
produced blue colonies and, therefore, were secreted in E. coli. Nine ML genes (fbpC, lpqC,
ML0885, lpqF, fbpB, ML2274, ML2331, ML2569 and mce1C) were unable to be cloned in
E. coli. A simple explanation for these results is that the 9 unclonable mycobacterial proteins
were toxic for E. coli. Jobling, et al, 1997, reported that the production of wild type cholera
toxin as a periplasmic protein was toxic for E. coli, but by replacing the native signal
sequence with an E. coli signal sequence they were able to produced cholera toxin protein in
high yield in E. coli. While the ML proteins were clearly not toxins like cholera toxin, many
proteins are difficult to clone in E. coli for myriad reasons involving such as blockage of
metabolic pathways to binding and disrupting membranes and others physiologically
important structures. For example, E. coli may be unable to process mycobacterial
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lipoproteins or other Sec-dependent motifs found in some ML signal peptides, leading to
build up of these proteins eventual toxicity to E. coli.
PhoA fusion studies using pJEM11 showed that only 2 proteins (ML0715 and
ML2569) produced blue colonies and, therefore, were secreted in M. smegmatis. Both
proteins are thought to be lipoproteins based on the presence of a conserved motif. Lim, et
al, 1995, used pJEM11 to construct an M. tuberculosis DNA library of fusions to the PhoA
gene and identified a sequence corresponding to the exported 19kDa lipoprotein.
Lipoproteins have been found in both Gram-negative and Gram-positive bacteria; however,
differences in the conserved motif of lipoproteins or in the specificity of signal peptidase II to
process lipoproteins may exist in E. coli making secretion impossible.
The low number of detectable ML proteins secreted by M. smegmatis could be related
to the presence of mutations or deletions in the ML genes that produced an out of frame ML
gene-phoA fusion. The sequence data for the 7 ML genes cloned in M. smegmatis is not
complete, therefore, it is possible that all or some white colonies are M. smegmatis
transformants carrying mutations of the ML genes resulting in defective phoA fusions. The
expression of PhoA from pJEM11 in M. smegmatis depends on translational fusion with
amino termini of the cloned ML proteins and the presence of a functional promoter. Of 10
ML genes that were selected for cloning into pJEM11, only 4 showed a putative promoter
area (-35 and -10 sites) located 100 to 200 bases upstream from the starting codon. However,
strict definition of mycobacterial promoters is still undefined and the potential for some of
these genes to be within operons can not be ruled out.
Three ML proteins (ML0620, ML0885 and ML1812) were unable to be cloned in M.
smegmatis and may be due to procedural issues. It is possible that some ML genes require
specific environmental conditions (e.g. intracellular) for expression or for their product to be
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exported. In addition, at the level of promoter recognition and transcription initiation
controlled by the sigma factors of RNA polymerase, there may be significant differences
between M. leprae and M. smegmatis blocking gene expression. Comparative genomic
studies of M. leprae and M. tuberculosis have shown a significantly lower number of sigma
factors in M. leprae (Cole et al, 2001).
The E. coli and M. smegmatis secretion vectors were available for this study and were
used before to validate secretion in M. tuberculosis. E. coli vector showed more ML proteins
secreted (5 out of 6) under a strong E. coli promoter. In addition, the alkaline phosphatase
activity was detected in 2 days in Luria agar supplemented with the appropriate substrate. A
disadvantage of using E. coli is the incompatibility to process post translational modifications
(e.g. lipoproteins). M. smegmatis vector showed less ML proteins secreted (2 out of 7), and
maybe due to weak ML promoters. The alkaline phosphatase activity was detected after 7-14
days in Luria agar supplemented with the appropriate substrate.
The Sec pathway for secretion is present in both M.leprae and E. coli but there appear
to be some differences. For example, the absence of SecB and the presence of two SecA
genes in Mycobacterium spp (Braunstein et al, 2001) could make the process of translocation
slightly different. SecB acts as a chaperone and binds SecA, but it has been only found in
Gram-negative bacteria. By comparison mycobacteria and some other Gram-positive bacteria
code two SecA proteins. It is thought that the two proteins might be involved in exporting
different subsets of proteins. In addition, the signal sequences for secretion described for
Gram-negative and Gram-positive bacteria are not identical. Therefore, some of the
mycobacterial signal sequences might not be recognized by the E. coli Sec-dependent
pathway. Taken together these differences may explain why 9 of 15 ML proteins were not
expressed in E. coli.
78

In order to study gene expression in M. smegmatis as a function of transcription, RTPCR was performed. Transcripts were identified for 7 ML genes cloned in M. smegmatis
(ML0091, ML0097, ML0098, ML0715, ML2028, ML2380 and ML2569). These data
confirm that the required genetic elements for transcription are present in pJEM11.
White colonies recovered from M. smegmatis transformants (ML0091, ML0097,
ML0098, ML2028 and ML2380 might represent mutants resulting in a defective phoA fusion
or transformants lacking the required genetic elements for translation or secretion. In order to
study protein expression of the 5 recombinant M. smegmatis white colonies immunoblot
detection of phoA fusion proteins was performed. Under these conditions, ML recombinant
protein was not observed in the blots. These results suggest that the phoA gene is not in frame
with some or all the M. smegmatis white transformants due to mutations in ML genes. The
M. smegmatis blue transformants showed alkaline phosphatase activity in Luria agar plates
and therefore have a functional phoA gene, however, the transcription of phoA may be under
a weak promoter. ML0091, ML0097 and ML0620 recombinant proteins from E. coli
transformants were identified by immunoblot detection with monoclonal antibodies antiPhoA, ML0620 complete sequence was confirmed in E. coli.
The experiments in this dissertation showed indirect evidence of Sec-dependent
mechanisms for secretion in M. leprae. The possibility that some or all of these ML secreted
proteins were translocated in E. coli or M. smegmatis by a different secretion pathway (Ex.
Sec-independent pathway), cannot be ruled out.
In summary, the analysis of PhoA fusions validated 5 of 6 ML proteins (83%) in E.
coli and 2 of 7 ML proteins (29%) in M. smegmatis. By comparison, Gomez et al, 2000,
identified 52 M. tuberculosis predicted secreted proteins by computer-based analysis and 9 of
10 (90%) were confirmed using PhoA gene fusions in E. coli. These results suggest that
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predictions for secretion in M. leprae using Signal P and TMHMM are useful in selecting
Sec-dependent secreted proteins.
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CONCLUSIONS
1) Bioinformatic Tools Predict Sec-dependent Protein Secretion in M. leprae
Bioinformatic tools trained to recognize secreted proteins were used to predict the
existence of secreted proteins in M. leprae. Sequences for two hundred and four M.
tuberculosis proteins either known to be or predicted to be secreted constituted the set of
gene sequences from which M. leprae homologs were selected. Fifty-two MT proteins were
not found in the M. leprae genome and 38 MT proteins were related to ML pseudogenes.
Analysis of the remaining 114 homologs with SignalP and TMHMM predicted that 24 ML
proteins display characteristics consistent with secretion via the sec-dependent protein
secretion pathway.
M. leprae signal sequences were found to be very similar to other Gram-positive and
M. tuberculosis signal sequences. Cleavage sites were conserved and the N-regions from
ML signal sequences showed a high arginine content (19%) similar to that found in M.
tuberculosis (22%) Sec-dependent secreted proteins.
Many fewer secreted proteins were predicted in M. leprae (24) compared to M.
tuberculosis (52). This discrepancy is also observed in the number of functional genes in M.
tuberculosis (3959) compared to M. leprae (1604) and may be the result of a severely
diminished genome in M. leprae due to evolutionary pressures. These data supported earlier
speculation that since M. leprae has undergone a severe loss of genes due to a reductive
evolutionary process, the remaining genes of M. leprae may define a minimal set of genes
necessary for growth and survival of an intracellular mycobacterial pathogen.
2) All 15 ML Predicted Secreted Proteins Were Transcribed During Intracellular
Growth in Nude Mice
Analysis of M. leprae growing in nude mice identified transcripts for all 15 putatively
secreted protein genes of M. leprae. Seven of these M. leprae proteins have been associated
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with potential virulence factors in M. tuberculosis and correlates with the observation that the
majority of bacterial virulence factors are extracytoplasmic proteins.
3) Secretion of 83% of the ML Predicted Secreted Proteins Was Verified by PhoA
Fusion Analyis in E. coli and Secretion of 29% of the ML Predicted Proteins Was
Verified by PhoA Fusion Analysis in M. smegmatis
By comparison, Gomez et al, 2000, identified 52 M. tuberculosis predicted proteins
using bioinformatic tools and 90% were verified by phoA fusion analysis in E. coli. These
results suggest that predictions for secretion in M. leprae using bioinformatics tools are
useful in selecting Sec-dependent secreted proteins. My data also suggest that validation of
secretion in M. smegmatis can help extend coverage of potential secreted proteins to include
lipoproteins of M. leprae.
Future studies will be directed to investigate the relevance of the two ML lipoproteins
(ML0715 and ML2569) secreted in M. smegmatis and the 5 ML proteins (ML0091, ML0097,
ML0620, ML1811, ML1812) secreted in E. coli as potential vaccines or diagnostic reagents
for controlling leprosy. Because these ML proteins showed a relatively high amino acid
identity with M. tuberculosis, they could be developed as vaccine candidates for both leprosy
and tuberculosis. ML secreted proteins could be delivered as DNA vaccines using a strong
eukaryotic promoter. In addition, these ML secreted proteins could be used to improve BCG
vaccines by creating new over-expressing recombinant BCG strains.
These ML secreted proteins may not be good candidates for M. leprae-specific
diagnostic reagents for leprosy because of the relatively high amino acid homology between
the ML proteins and their M. tuberculosis homologs. However, it is possible that these
secreted ML proteins and MT proteins have unique epitopes engendering immunological
specificity for ML or MT.
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Finally, some of the ML secreted proteins identified in this study have not been
annotated and therefore, may have unique functional or structural capacities. Further studies
into their function and immunogenicity could lead to a fuller understanding of the host
immune response during infection and to the disease causing potential of M. leprae.
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